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ABSTRACT 
 Agricultural pests are a worldwide problem and cause billions of dollars in crop 
loss. In the United States alone, an estimated $40 billion USD is lost per year due to 
insecticide resistance [1]. Studied here are proteins (potentially new pesticide targets) from 
the agricultural pests Tetranychus urticae and Aspergillus fumigatus. T. urticae, or two-
spotted spidermite, is a polyphagous pest, and three proteins from this pest, a cyanase, a 
glutathione S-transferase and an intradiol ring-cleavage dioxygenase are described [2]. 
Cyanase is involved in the conversion of bicarbonate and cyanate, a toxic self-defense 
metabolite produced by plants, into ammonia and carbon dioxide. Glutathione S-
transferase conjugates reduced glutathione to xenobiotics for detoxification and have been 
associated with insecticide resistance [3]. Intradiol ring-cleavage dioxygenase is involved 
in the breakdown and metabolism of toxic aromatic compounds.  
 Furthermore, A. fumigatus is a ubiquitous fungus that is not only a problem in 
agriculture, but also in healthcare. A. fumigatus  drug resistance is becoming more 
prominent which is mainly attributed to the widespread use of fungicides in agriculture [4]. 
The 2-methylcitrate cycle, which is only present in fungi, is responsible for detoxifying 
propionyl-CoA, a toxic metabolite produced as the fungus breaks down proteins [5]. The 
enzyme responsible for this detoxification is 2-methylcitrate synthase (mcsA) and is a 
potential candidate for the design of new anti-fungals. However, mcsA shares a similar 
reaction to human citrate synthase (hCS), and both the structure and function of each 
enzyme is studied in parallel to find mcsA-specific inhibitors.
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CHAPTER 1 
STRUCTURAL CHARACTERIZATION OF A EUKARYOTIC CYANASE FROM 
TETRANYCHUS URTICAE 
 
1.1 BACKGROUND AND INTRODUCTION 
Chelicerates are a basal lineage within the Arthropoda phylum and represent the 
second largest group of terrestrial animals after insects [6]. They comprise of horseshoe 
crabs, scorpions, spiders, mites and ticks and include various economically important 
species for human health and agriculture. Mites exhibit a diverse range of lifestyles 
including herbivory, predation, parasitism, detritivory and symbiosis [7, 8]. With 48,000 
species described by the turn of the century [9] and a total estimate of 0.5 and 1 million 
species, mites are probably one of the most diverse animal groups [10]. The two-spotted 
spider mite (TSSM), Tetranychus urticae, is an agricultural herbivorous pest and is the first 
chelicerate for which the complete genome was sequenced [11]. Due to its rapid 
developmental rate (can reach adulthood from egg in 7 days at 30°C), easy laboratory 
rearing and strong research community, T. urticae is presently a versatile chelicerate model 
organism [12]. Moreover, its compact genome of 90 Mbp (54% of the genomic sequence 
encodes for proteins) makes it an attractive experimental system to investigate gene and 
protein function. 
TSSM is one of the most polyphagous arthropods, feeding on more than 1,100 plant 
species including more than 150 agricultural crops [13]. As plants produce a vast number 
of secondary metabolites, whose composition varies qualitatively and quantitatively with
2 
and between species [14], TSSM is able to overcome a plethora of plant defense systems 
[15]. TSSM infestations are controlled with acaricides of which the global market value is 
estimated at $1.6 billion [16]. The TSSM has the highest incidence of pesticide resistance, 
resulting in extreme difficulty of controlling populations by conventional chemical pest 
management [17]. Analyses of the TSSM genome have previously revealed an 
unprecedented proliferation of multi-gene families that are commonly associated with the 
xenobiotic metabolism. These lineage-specific expansions in families such as cytochrome 
P450 monooxygenases and ABC transporters are considered to strongly contribute to the 
mite’s ability to quickly develop pesticide resistance and to adapt to a wide host plant range 
[11, 18, 19]. In addition, spider mite outbreaks and crop damage are strongly facilitated by 
high temperatures and drought stress, both of which are intensified by climate change [20]. 
With increased reproductive potential under conditions of global warming [21], combined 
with an outstanding ability to adapt to new crops and develop resistance to pesticides, the 
TSSM is becoming a high-risk pest threatening global crop security.  
Many plant species, including a number of food plants, are cyanogenic and release 
toxic hydrogen cyanide (HCN) from non-toxic glycoside or lipid precursors upon herbivore 
attack [22, 23]. Previous studies have gathered a body of evidence showing that the TSSM 
overcomes cyanide toxicity by expressing genes of foreign origin within its genome 
acquired through the process of horizontal gene transfer [24, 25].  
Two mutually non-exclusive cyanide detoxification pathways, catalyzed by two 
horizontally transferred genes, have been proposed for TSSM. Cyanide might be first 
oxidized to cyanate (OCN-) which is then catabolized by the horizontally acquired T. 
urticae cyanase enzyme into ammonia and carbon dioxide [24]. It was shown that the 
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cyanase gene was transcribed in all mite feeding stages (larvae, nymphs and female adults) 
and that gene-expression was host plant dependent. However, a later study revealed the 
presence of yet another gene from bacterial origin that codes for a β-cyanoalanine synthase 
enzyme that directly detoxifies cyanide through the formation of the amino acid derivative 
β-cyanoalanine [25]. This raises the question whether cyanide detoxification is the main 
function of T. urticae cyanase (in this manuscript further referred to as TuCyanase). The 
genomes of some non-phytophagous mites also possess cyanase genes [15]. Cyanate is also 
formed by the dissociation of carbamoyl phosphate and inhibits further synthesis of the 
compound by interacting with carbamoyl phosphate synthase. As carbamoyl phosphate is 
a main substrate for arginine and pyrimidines biosynthesis, cyanase might be indirectly 
involved in the regulation of their biosynthesis by changing cyanate concentrations [22, 
23, 26–28]. To better understand the biological function of the horizontally transferred 
cyanase genes and their protein products, it is of crucial importance to understand the 
quaternary structures and how these evolved after a horizontal transfer event.  
Cyanases in nematodes, plants and fungi are not very well characterized and the 
enzyme from E. coli is the most studied representative of this group of enzymes [26, 29–
34]. It was shown that the E. coli cyanase (here referred to as EcCyanase) is a decameric 
protein that uses bicarbonate and cyanate as substrates (Figure 1.1) [35]. The enzyme is 
inhibited by various anions such as chloride, azide, nitrate, oxalate, oxaloacetate and 
malonate. Moreover, bicarbonate at high concentrations is responsible for substrate 
inhibition of the enzyme. Several structures of the E. coli enzyme have been determined 
[34]. At the time of this publication, the only other cyanase structure present in the Protein 
Data Bank (PDB) originates from the bacteria Serratia proteamaculans (SpCyanase) [36].  
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The TuCyanase presented here is the first mite cyanase that has had its structure 
determined, and is also the very first structure of any eukaryotic cyanase. This manuscript 
discusses in detail the differences between bacterial and TuCyanase which have a similar 
overall fold, despite relatively low sequence identity. Our structural and functional data 
provide a deeper understanding on the role of cyanase in T. urticae and other mites. 
1.2 PURIFICATION OF RECOMBINANT T. URTICAE CYANASE 
Originally, tetur28g02430 (TuCyanase) was ordered from DNA 2.0 (Menlo Park, 
CA) in the expression vector pJExpress411 (Kanamycin resistance (KAN)) that has an 
isopropyl β-D-1-thiogalactopyranoside (IPTG)-inducible T7 promoter. The gene was 
synthesized to contain an N-terminal cleavable 6xHis-tag for ease of purification with the 
Tobacco Etch Virus (TEV) cut site MHHHHHHSSGVDLGTENLYFQ/SGSG where the 
cut site is shown with a slash. DNA was transformed into BL-21 (DE3) E. coli via heat 
shock and cells were plated on Luria-broth (LB)-KAN (50 µg/mL) plates at 37ºC for 16 
hours. For inoculation, 10 mL of starter culture was used in 1.0 L of LB containing 50 
µg/mL KAN. Cultures were shaken at 37ºC until an OD of 0.8 was reached and then cooled 
down to 16ºC for protein expression with 0.4 mM IPTG for 16 hours. Cell pellets were 
harvested by spinning cultures in a Beckman Coulter Ultracentrifuge (Indianapolis, IN) at 
4ºC which were immediately frozen at -80ºC until needed further. 
 Pellets were resuspended in lysis buffer (50 mM Tris pH 7.4, 500 mM NaCl, 2% 
glycerol, 20 mM β-mercaptoethanol (β-ME), 10 mM imidazole) using 5.0 mL buffer per 
gram of pellet and lysed by sonication using a Branson Sonifier 450 (ThermoFisher, Grand 
Island, NY). Cell lysate was spun down in a Beckman Coulter Ultracentrifuge 
(Indianapolis, IN) at 4ºC and supernatant was loaded onto a 5.0 mL resin bed of HisPur 
NiNTA Resin (ThermoScientific, Grand Island, NY) equilibrated in wash buffer (50 mM 
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Tris pH 7.4, 500 mM NaCl, 2% glycerol, 20 mM β-ME, 30 mM imidazole). The column 
was washed several times with wash buffer and protein was eluted with elution buffer (50 
mM Tris pH 7.4, 500 mM NaCl, 20 mM β-ME, 250 mM imidazole). Elutions were 
collected in 1.5 mL fractions and run on a 12% SDS-PAGE gel to determine fractions that 
contain protein. Elutions containing protein were put into SnakeSkin Dialysis Tubing with 
a 3,000 molecular weight (MW) cutoff (ThermoScientific, Grand Island, NY) and dialyzed 
in dialysis buffer (10 mM Tris pH 7.4, 150 mM NaCl, 5 mM β-ME) at 4ºC for 16 hours. 
TuCyanase was concentrated using an EMD Millipore Amicon Ultra-15 concentrator 
(Billerica, MA) with a 3,000 MW cutoff, and concentration was determined by A280 using 
the molar extinction coefficient 18,910 M-1cm-1 and MW 18,540 as determined by the 
ExPASy ProtParam tool [37, 38]. 
 Purification of TuCyanase with N-terminal his-tag resulted in very poor yields of 
protein (around 1.0 mg per liter culture). Figure 1.2A shows a 12% SDS-PAGE gel for Ni-
NTA purification results of this protein. To increase yield, the fusion protein maltose-
binding protein (MBP) was used in pMBPcs1.  
1.3 CONSTRUCTION OF PMBPCS1 AND CLONING OF T. URTICAE CYANASE 
CONSTRUCTION OF PMBPCS1 
 The base vector for making pMBPcs1 was pMCSG71 [39] from DNASU Plasmid 
Repository (Tempe, AZ). This pMCSG71 vector expresses fusion protein as follows: MBP, 
Tobacco Vein Mottling Virus (TVMV) cut site, Ligation Independent Cloning (LIC) site, 
TEV cut site, 6xHis-tag where the LIC site is the location of gene insertion. The end 
product pMBPcs1 was designed to express the fusion protein as follows: MBP, AlaAlaSer-
linker, TuCyanase (LIC site), TEV cut site, 6xHis-tag. The megaprimers labeled as 
pCSAA-F and pCSAA-R in Table 1.1 were used to knockout the TVMV cut site in 
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pMCSG71 and replace it with two alanine codons (AGCAGC); the serine of the AAS linker 
was added to the 5’ end of the TuCyanase insert later in the process. Primers were designed 
using the program on rf-cloning.org [40]. First, megaprimers were synthesized in a 50 µL 
primary reaction by mixing 10 µM of each primer (pCSAA-F and pCSAA-R) with phusion 
polymerase following the manufacturer's setup protocol (NEB, Ipswich, MA) and 
thermalcycling as follows: initial 98ºC for 30 seconds, 15 cycles of 98ºC for 10 seconds, 
58ºC for 15 seconds, 72ºC for 10 seconds, a final extension at 72ºC for 30 seconds and an 
infinite hold at 12ºC.  
 After the primary polymerase chain reaction (PCR), secondary PCR was performed 
by adding 1.0 µL of 100 ng pMCSG71 to the primary PCR and thermalcycling as follows: 
initial 98ºC for 30 seconds, 35 cycles of 98ºC for 10 seconds, 64ºC for 30 seconds, 72ºC 
for 6 minutes, a final extension at 72ºC for 10 minutes and an infinite hold at 12ºC. Twenty 
units of DpnI (NEB, Ipswich, MA) were added to the secondary PCR and incubated at 
37ºC for 2 hours. DpnI was then inactivated at 80ºC for 20 minutes. For transformation, 20 
µL of secondary PCR was added to chemically competent DH5-α E. coli cells and heat 
shocked at 42ºC for 45 seconds. Cells were allowed to recover by adding 950 µL of super 
optimal broth (SOC) media and incubated at 37ºC for 1.0 hour with shaking. Cells were 
plated on LB-ampicillin (AMP) plates (50 µg/mL) and grown at 37ºC for 16 hours. Clones 
were miniprepped with a GeneJET Plasmid Miniprep Kit (ThermoFisher, Grand Island, 
NY) and sent to EtonBioscience (Research Triangle Park, NC) to confirm the correct 
sequence with T7 forward and T7 reverse primers. 
CLONING OF TUCYANASE INTO PMBPCS1 
 
 After the correct sequence was confirmed for pMBPcs1 (Figure 1.3), TuCyanase 
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(Uniprot: T1KZQ3) from DNA 2.0 (Menlo Park, CA) was cloned into it using Ligation 
Independent Cloning. For LIC, pMBPcs1 was amplified at the LIC site to generate blunt 
ends for T4 DNA Polymerase 3' → 5' exonuclease activity using the primers pMBPcs1-
LIC-F and pMBPcs1-LIC-R in Table 1.1. The PCR was performed following the standard 
protocol for KOD Polymerase (EMD Millipore, Billerica, MA) with the addition of 1.0 M 
betaine monohydrate, 2.0 mM magnesium sulfate and 130 ng of pMBPcs1 in a 50 µL 
reaction with thermalcycling as follows: initial 95ºC for 2 minutes, 30 cycles of 95ºC for 
20 seconds, 54ºC for 10 seconds, 70ºC for 6 minutes, a final extension at 70ºC for 10 
minutes and an infinite hold at 12ºC. The reaction was run on a 1.0% agarose gel and the 
band corresponding to pMBPcs1 was gel excised using a GeneJET Gel Extraction Kit 
(ThermoFisher, Grand Island, NY) and eluted with sterile water.  
 TuCyanase was prepared for LIC into pMBPcs1 by using pMBP-Cyan-F and 
pMBP-Cyan-R primers listed in Table 1.1; the forward primer for TuCyanase was designed 
to introduce a serine residue at the N-terminal of cyanase so the fusion protein linker would 
be three residues consisting of AlaAlaSer. For PCR, TuCyanase in pJExpress411 from 
DNA 2.0 (Menlo Park, CA) was used as the template (100 ng) and the protocol for Phusion 
polymerase was used (NEB, Ipswich, MA). The conditions for thermalcycling were as 
follows: initial 98ºC for 30 seconds, 35 cycles of 98ºC for 10 seconds, 70ºC for 30 seconds, 
72ºC for 25 seconds, a final extension at 72ºC for 1.0 minute and an infinite hold at 12ºC. 
PCR product was run on a 1.0% agarose gel and gel excised using a GeneJET Gel 
Extraction Kit (ThermoFisher, Grand Island, NY) and eluted with sterile water. 
 Sticky ends for LIC were made by incubating gel excised PCR products with T4 
DNA polymerase (NEB, Ipswich, MA). A 40 µL reaction containing 600 fmoles of 
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pMBPcs1, 5.0 mM dithiothreitol (DTT), 2.5 mM deoxyadenosine triphosphate (dATP), 1X 
NEB2.1 buffer and 3.0 units of T4 DNA polymerase, and a 40 µL reaction containing 1500 
fmoles of tetur28g02430, 5.0 mM DTT, 2.5 mM deoxythymidine triphosphate (dTTP), 1X 
NEB2.1 buffer and 3.0 units of T4 DNA polymerase were incubated at room temperature 
for 30 minutes. The T4 DNA polymerase was then inactivated at 75ºC for 20 minutes and 
the reactions were mixed 10:10 at room temperature for 5.0 minutes. Next, 1.0 µL of 25 
mM ethylenediaminetetraacetic acid (EDTA) was added and the reaction was incubated 
another 5.0 minutes at room temperature. Transformation was performed with heat shock 
as mentioned previously after adding the 20 µL LIC reaction to the cells, and cells were 
plated on LB-AMP (50 µg/mL) plates at 37ºC for 16 hours. Clones were miniprepped with 
a GeneJET Plasmid Miniprep Kit (ThermoFisher, Grand Island, NY) and insertion of 
TuCyanase was first confirmed by restriction digest with HindIII and XbaI following the 
manufacturer's instructions (NEB, Ipswich, MA). After restriction digest, clones with 
correctly sized fragments were sent to EtonBioscience (Research Triangle Park, NC) for 
sequencing with T7 forward and T7 reverse primers. Correct clones were transformed via 
heat shock into BL-21 (DE3) E. coli cells. 
1.4 PURIFICATION OF MBP-CYANASE 
 Purification of MBP-Cyanase was the same as previously mentioned for cyanase 
except it yielded much higher quantities of protein (around 30 mg per liter culture, Figure 
2B) and dialysis buffer contained 5.0 mM maltose. MBP-Cyanase concentration was 
determined by A280 using the molar extinction coefficient 85,260 M
-1cm-1 and MW 60,834 
as determined by the ExPASy ProtParam tool [37, 38]. MBP-Cyanase was further purified 
with a Superdex 200PG column attached to an ÄKTA Pure FPLC system (GE Healthcare, 
Marlborough, MA) equilibrated in FPLC buffer (10 mM Tris pH 7.4, 150 mM NaCl, 5.0 
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mM maltose). Gel filtration results are shown in Figure 1.4. Interestingly, MBP-Cyanase 
eluted off the column as a single peak around a size of 670 kiloDaltons (kDa) (based on 
Bio-Rad (Hercules, CA) Thyroglobulin 670 kDa standard), which would indicate the 
fusion protein is in a decameric state. 
1.5 CONFIRMATION OF CYANASE ACTIVITY OF MBP-CYANASE 
To determine if the MBP-cyanase fusion protein had enzymatic activity, MBP-
Cyanase was incubated in a 500 µL reaction of 100 mM Tris pH 7.5 with 10 mM sodium 
cyanate and 10 mM sodium bicarbonate; all chemicals used were purchased from Sigma-
Aldrich. To detect the presence of ammonia, one product of the cyanase reaction, a piece 
of Whatman pH paper dampened with diH2O was placed above the opening of the 1.5 mL 
tube containing the 500 µL reaction mix. After ~20 seconds, the pH paper turned green 
which would indicate the presence of base i.e. ammonia (data not shown). As negative 
controls, reactions were made as follows: only sodium bicarbonate, only sodium cyanate, 
both sodium bicarbonate and sodium cyanate, sodium bicarbonate with Tris pH 7.5 and 
MBP-Cyanase, sodium cyanate with Tris pH 7.5 and MBP-Cyanase. These controls were 
all tested with pH paper in the same manner. All of the controls failed to change the color 
of the pH paper, except the Tris reaction mix containing sodium cyanate and MBP-
Cyanase. It is possible that residual bicarbonate (from atmospheric CO2) was present after 
the purification of MBP-Cyanase, even though bicarbonate was not used during 
purification. 
1.6 CRYSTALLIZATION OF MBP-CYANASE 
MBP-Cyanase crystallization experiments were performed at room temperature 
using the sitting-drop vapor diffusion method and MRC 2-drop 96-well crystallization 
plates (Hampton Research, Aliso Viejo, CA). Recombinant protein (~13 mg/mL) was 
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mixed with mother liquor in a 1:1 ratio. A condition of 0.1 M Tris pH 7.5, 15% w/v 
PEG6000 produced crystals after about 2 months. Crystals were cryo-cooled in liquid N2.  
1.7 DATA COLLECTION, STRUCTURE DETERMINATION AND REFINEMENT OF 
TUCYANASE 
Data was collected using remote access to Southeast Regional Collaborative Access 
Team (SER-CAT) 22ID at the Advanced Photon Source (APS), Argonne National Lab 
(Argonne, IL). The diffraction images were processed with the HKL-2000 software 
package [41]. Data collection statistics are reported in Table 2. Molecular replacement was 
performed using MOLREP [42] integrated with HKL-3000 [43]. The crystal structure E. 
coli cyanase (PDB code: 2IV1) was used as the starting model for molecular replacement. 
The initial model was rebuilt using BUCCANEER [44] and CCP4 package [45]. 
Refinement was performed using REFMAC [46] and HKL-3000. Non-crystallographic 
symmetry was used during the whole process of refinement. TLS refinement was used 
during the last stages of the refinement and the TLS Motion Determination server was used 
for partitioning protein chains into the rigid bodies undergoing vibrational motions [47]. 
The model was updated and validated with COOT [48]. MOLPROBITY was used in the 
final steps of the model validation [49]. The final model together with structure factors 
were deposited to the Protein Data Bank [50] with the accession number 5UK3. Dali [51] 
and PDBeFold [52] were used to identify structural homologs of the T. urticae cyanase. 
PDBePISA [53] was used to analyze oligomeric assembly formed by the enzyme. Figures 
were created with PyMOL [54].   
1.8 OLIGOMERIC ASSEMBLY OF TUCYANASE 
The recombinant MBP-cyanase protein was shown to be enzymatically active by 
detecting the accumulation of the reaction product ammonia in the reaction mix (data not 
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shown). Although the recombinant protein was unstable at room temperature after 4-5 days 
(data not shown), we were still able to crystallize TuCyanase. The model presented here is 
the first mite cyanase structure determined and the first structure of any eukaryotic cyanase 
(Figure 1.5). The comparison of T. urticae cyanase to the two known bacterial cyanase 
structures revealed that a homo-decameric state and active site residues were conserved, 
but there were some variabilities in the dimer interfaces and protein domains. 
Consequently, TuCyanase appears to be less compact than the prokaryotic cyanases, 
EcCyanase and SpCyanase.  
Structural analysis revealed that only the cyanase part of MBP-Cyanase is present 
in the crystal. The crystal form contained 10 protein chains in the asymmetric unit (AU). 
The quaternary structure was determined to be decameric which is in agreement with gel 
filtration results (Figure 1.4), as well as the oligomeric forms observed for EcCyanase [34] 
and  SpCyanase [36]. The decamer may be treated as a pentamer of dimers (Figure 1.6A). 
A single protein chain is composed of two segments: an N-terminal domain (helices α1-
α5) and the cyanate lyase domain (all β-strands and helix α6). The role of the N-terminal 
domain is not well understood and has a similar structure to some proteins involved in 
DNA binding. For example, a structural domain part of cytolysin repressor 2 from 
Enterococcus faecalis (PDB code: 2XJ3) overlaps with an RMSD of 1.8 Å (over 58 Cα 
atoms). The cyanate lyase domain of TuCyanase contained all amino acids necessary to 
form the active site.  
The determined cyanase structure from T. urticae included mostly residues 22-156 
with a small variability of the sequence span between the 10 protein chains in the 
asymmetric unit. Comparison of the TuCyanase structure with the bacterial homologs from 
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E. coli and S. proteamaculans revealed a significant degree of structure similarity despite 
a relatively low sequence identity (Figure 1.5, 1.7). The sequence identity/similarity 
between T. urticae and E. coli or S. proteamaculans proteins is 35%/62% or 34%/56% 
respectively, with the N-terminal domains being less conserved in comparison with the 
cyanate lyase domains. Superposition of TuCyanase and EcCyanase or SpCyanase 
structures resulted in RMSD values of 1.8Å (over 129 Cα atoms; PDB code 1DW9) or 
1.7Å (over 128 Cα atoms; PDB code 4Y42), respectively. 
1.9 DIMER INTERFACE OF TUCYANASE 
 
As mentioned before, functionally active cyanase enzymes of T. urticae and 
bacteria form a decamer that may be described as a pentamer of dimers. The dimer interface 
(interface 1, Figure 1.6B) has a very large area (~3050 Å2 for T. urticae and ~3250 for E. 
coli). In addition, each protein chain forming the dimer interacts with four other protein 
chains from neighboring dimers (Figure 1.6B). In TuCyanase, interface 2 (blue and yellow 
chains) had a relatively large area (~1200 Å2) compared to interfaces 3 (blue and green), 4 
(blue and brown) and 5 (blue and red) which were relatively small (~260 Å2 each); a 
significant degree of interface 2 was formed by the C-terminal end of a neighboring unit. 
The decamer is barrel-shaped with a height of approximately 70 Å and diameter of 75 Å. 
Compared to TuCyanase, EcCyanase is more compact with larger interface areas between 
the monomers and neighboring dimers: interface 1 is ~3250 Å2, interface 2 is ~1400 Å2, 
interface 3 and 4, are ~800 Å2, interface 5 is ~300 Å2). Despite differences in compactness 
and interface areas, the decameric barrel of TuCyanase and EcCyanase have a similar 
height and diameter. 
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The major difference in the oligomeric forms observed for proteins from T. urticae 
and E. coli (as well as S. proteamaculans) is related to the fact that the spider mite protein 
structure does not possess the first 20 amino acids. These missing amino acids correspond 
to a fragment of helix α1 in the E. coli structure and N-terminal part that does not have a 
defined secondary structure; it is placed on the “edge” of the barrel mediating contact 
between dimers. The presence of the N-terminal amino acids in the E. coli structure 
increases the surface area interface between dimers by almost 40% in comparison with the 
corresponding interactions in the structure for T. urticae. In addition, in E. coli cyanase the 
N-terminal part of the protein is packed in the barrel, thus limiting the size of the substrate 
channel through the decamer. The comparison of the TuCyanase and EcCyanase also shows 
that the helices α1 and α5 for EcCyanase are shifted significantly towards the center of the 
barrel.  
1.10 ACTIVE SITE OF TUCYANASE 
 
 Structural and sequence analyses of TuCyanase, EcCyanase and SpCyanase (Figure 
1.8) show that the most conserved amino acids are located in the areas mediating 
interactions between the dimeric assemblies. Two dimers are necessary to create an active 
site and there are five active sites in one decamer. Mapping of the sequence conservation 
onto the structure of TuCyanase clearly showed that the cyanate lyase domain is 
significantly more conserved than the N-terminal domain. The active site is composed of 
amino acids provided by four protein chains (Figure 1.9A). The studies of cyanase from E. 
coli identified the following residues as being critical for the protein activity: R96, E99 and 
S122 [34]. These residues correspond to R100, E103 and S126 from TSSM and are 
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conserved in all studied cyanases (Figure 1.9B) [24, 28, 55], including the recently 
discovered silverleaf whitefly homolog (R119, E122 and S145). 
 The cyanase active site is quite unusual as not only is it formed by residues 
originating from four protein chains, it also exhibits a pseudo-two-fold symmetry (Figure 
1.9C). The number and composition of the active sites are in agreement with the kinetic 
and binding studies that show 0.5 stoichiometry in the case of substrate and inhibitor 
binding [30]. At the entrance to the active site, K149 may help to attract negatively charged 
substrates. In addition, the entrance to the active site was aligned with hydrophobic residues 
like I124, I128 and L151 that limit the size of the molecules/ions that can access the active 
site. It is not clear what the role of S126 is during the reaction, but it is believed that R100 
is responsible for substrate binding, while E103 positions the arginine in proper orientation. 
There are also two proline residues that were conserved in the TuCyanase, EcCyanase and 
SpCyanase. The first proline (P96) changes the direction of polypeptide chain and initiates 
helix α6 that contains critical catalysis residues R100 and E103. The second proline (P152) 
ends a short β-strand (β2b). It is also worth mentioning that the regions between β1a and 
β1b (S126-A127-I128), as well as β2a and β2b (K149), contained residues that are highly 
conserved among cyanases. 
1.11 DISCUSSION 
 Although the results presented here provide a better understanding of the 
horizontally acquired TuCyanase, it remains unclear how the substrates and products enter 
and leave the active site, respectively. It was proposed that solvent exposed residues L151 
(Figure 1.9C) control the access to the active site [34, 36], and the reaction occurs through 
a random sequential mechanism [32]. The active sites have an overall net positive charge 
which provides some explanation as to how the anionic substrates bind. Furthermore, the 
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active site residues consist of arginine, serine and glutamic acid residues and are conserved 
among all cyanases including those from bacteria, fungi and T. urticae presented here [22, 
24, 28, 34, 36, 55]. While there is an agreement on the identity of major cyanase substrates 
(Figure 1.1), it is not clear what source(s) of protons is necessary for the reaction. 
EcCyanase and TuCyanase display a bell-shaped pH dependence of activity with maxima 
at 7.4 and 7.6 respectively [24, 29]. It seems that serines 126 (from two chains) are the only 
amino acids in the vicinity of the active site (Figure 1.9C) that may participate in a proton 
transfer. However, it cannot be excluded that these residues play a different role during the 
reaction.  
 Decomposition of cyanate and bicarbonate by cyanase (Figure 1.1) generates two 
molecules of carbon dioxide. The E. coli cyanase operon also includes a cynT gene that 
codes for a carbonic anhydrase which aids in the recycling of the produced carbon dioxide 
to bicarbonate [26, 35, 56]. The role of the anhydrase is not only important for carbon 
dioxide recycling, but more importantly, it prevents CO2 from escaping from the cell. In 
the absence of the anhydrase, the carbon dioxide diffuses faster from the cell than it would 
being hydrated to bicarbonate [56]. The escape of CO2 would lead to a depletion of cellular 
bicarbonate that in turn would affect various metabolic processes using HCO3-/CO2 as 
substrates [57]. Furthermore, in E. coli it was shown that deletion of the cynT gene results 
in growth inhibition and an inability to degrade cyanate [57]. The importance of the 
cyanase/anhydrase tandem in the detoxification of cyanate was also suggested in fungal 
Fusarium oxysporum species [58]. Therefore, we speculate that a similar situation takes 
place in T. urticae. It is also likely that the protons generated during CO2 recycling are used 
during the reaction catalyzed by cyanase (Figure 1.1). Carbonic anhydrases have been 
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identified within the animal kingdom and belong to the α- or β-carbonic anhydrase family 
[59, 60]. However, β-carbonic anhydrases with InterPro protein domains IPR001765 could 
not be detected, although 9 α-carbonic anhydrases with InterPro domain IPR001148 were 
found [11, 61].  
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1.12 TABLES 
 
Table 1.1: Primers used for cloning TuCyanase. Lowercase letters show the two alanine 
insertions for pMBPcs1-F/R. Primers pMBPcs1-LIC-F/R were used to amplify pMBPcs1 
at the LIC region to generate linear DNA for cloning. In pMBP-Cyan-F, lowercase letters 
show the introduction of a serine (codon AGT) at the N-terminal of tetur28g02430. 
Furthermore, the lowercase letters in pMBP-Cyan-R shows the C-terminal end of 
tetur28g02430 with the addition of an alanine (codon GCT) which was needed for LIC. 
 
Primer Sequence 
pMBPcs1-F 5' CCTGAAAGACGCGCAGACTAATTCGgctgctGGGGA 3' 
pMBPcs1-R 5' CGGATTGGAAGTACAGGTTCTCCCCagcagcCGAAT 3' 
pMBPcs1-LIC-F 5' GGGGAGAACCTGTACTTCCAATCCGCCGGG 3' 
pMBPcs1-LIC-R 5' AGCAGCCGAATTAGTCTGCGCGTCTTTCAG 3' 
pMBP-Cyan-F 5' TTCGGCTGCTagtcgtatctacagccgcttgtttcaaa 3' 
pMBP-Cyan-R 5' GGTTCTCCCCagcgtccagctggcctttgtaatacgg 3' 
 
 
 
  
18 
Table 1.2: Summary of data collection and structure refinement statistics for 
TuCyanase. Values in parentheses refer to the highest resolution shell. Abbreviations: AU 
– Asymmetric Unit. 
 
PDB Accession code 5UK3 
Data collection 
Diffraction source Synchrotron (APS 22ID) 
Wavelength (Å) 1.000 
a, b, c (Å) 71.1, 81.6, 136.5 
α, β, γ (°) 90, 100.4, 90 
Space group P21 
Solvent content (%) 50 
Protein chains in AU 10 
Resolution range (Å) 40.00-2.80 (2.85-2.80) 
Unique reflections 38010 (1906) 
Redundancy 4.1 (4.2) 
Completeness (%) 99.9 (100) 
Rmerge 0.069 (0.546) 
Rpim 0.050 (0.350) 
Rrim 0.102 (0.721) 
CC half (0.800) 
Average I/σ(I) 22.5 (2.0) 
Refinement 
Rwork 0.221 (0.341) 
Rfree  0.240 (0.346) 
Mean B value (Å2) 95.8 
B from Wilson plot (Å2) 93.3 
RMSD bond lengths (Å) 0.012 
RMSD bond angles (°) 1.7 
No. of amino acid residues 
A = 135; B,E,H = 137; 
C,D,F,G,J = 138; I = 141  
No. of water molecules 20 
Ramachandran plot 
Most favored regions (%) 98.9 
Additional allowed regions (%) 100.0 
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1.13 FIGURES 
 
 
 
Figure 1.1: Reaction scheme of cyanase. Cyanase catalyzes the reaction of bicarbonate 
with cyanate to form an intermediate, which is decarboxylated to give carbamate and 
carbon dioxide. The end products of the reaction are ammonia and carbon dioxide 
(carbamate decomposes nonenzymatically) [35]. 
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Figure 1.2: SDS-PAGE NiNTA purification of TuCyanase and MBP-Cyanase. A) SDS-
PAGE NiNTA TuCyanase purification. B) SDS-PAGE NiNTA MBP-Cyanase purification. 
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Figure 1.3: Plasmid map for pMBPcs1. The pMBPcs1 vector expresses fusion protein as 
MBP, AlaAlaSer Linker, Target Protein, TEV cut site, 6xHis-tag and operates under a T7 
promoter. MBP – Maltose Binding Protein, TEV – Tobacco Etch Virus, AMP – Ampicillin 
resistance, LIC – Ligation Independent Cloning Site, bps – basepairs. Plasmid map was 
made with the program pDRAW32. 
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Figure 1.4: Gel filtration results for MBP-Cyanase. One molecule of MBP-cyanase has 
a molecular weight of ~60 kDa. Standards used were thyroglobulin, ovalbumin, and 
myoglobin.  
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Figure 1.5: Oligomeric state of T. urticae and E. coli cyanases. Both form a pentamer 
of dimers and are shown in cartoon and surface representations with each monomer in a 
different color. Structures flipped 90° around the X-axis are also shown. 
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Figure 1.6: Cyanase dimer and surface interfaces. A) Structure of the TuCyanase dimer 
shown in cartoon representation. The dimer is shown in two orientations related by rotation 
of 180° along the Y-axis and each chain is depicted in a different color. Secondary structure 
elements are labeled on one of the chains forming the dimer. Residues forming active site 
are shown in stick representation (magenta) and are labeled. The dimer interface of two 
monomers for TuCyanase is ~3060 Å2 and for EcCyanase is ~3250 Å2. B) Space-filling 
models of TuCyanase and EcCyanase. The interfaces formed with neighboring dimers by 
one monomer (blue) are shown with the numbers 2, 3, 4 or 5. The area for surface interfaces 
2, 3, 4 and 5 are ~1200 Å2, ~270 Å2, 270 Å2 and 270 Å2 for TuCyanase and ~1410 Å2, 800 
Å2, 800 Å2 and 295 Å2 for EcCyanase, respectively. Surface interface areas were calculated 
using PDBePISA. 
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Figure 1.7: Amino acid sequence alignment of T. urticae, S. proteamaculans and E. 
coli cyanases. Conserved active sites residues are marked with blue stars, while the arrow 
indicates the end of the N-terminal domain and beginning of the cyanate lyase domain. Red 
boxes indicate identical residues whereas blue boxes indicate similar residues. The 
sequence identity/similarity between T. urticae and E. coli or S. proteamaculans proteins 
is 35%/62% or 34%/56% respectively. 
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Figure 1.8: Amino acid sequence conservation between TuCyanase, EcCyanase and 
SpCyanase. Residues that are identical in all structures are colored in red and residues that 
are similar are colored in dark gray. Residues that are not identical or similar are colored 
white. 
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Figure 1.9 The active site of cyanase from T. urticae. A) Cartoon representation of active 
site cyanase formed from 4 monomers. B) The active site is formed by residues R100, S126 
and E103 originating from four different protein chains (shown in four different colors). 
The residues forming the active site are shown in stick representation and are labeled. 
Oxalate (yellow) is modeled in the active site. The position of oxalate was derived from 
EcCyanase structure (PDB code: 2IU7). C) The active site of the TuCyanase is formed by 
residues from four adjacent protein chains (each colored differently) and all residues near 
the vicinity of the active site that were conserved in the enzymes from T. urticae, E. coli 
and S. proteamaculans are shown. 
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CHAPTER 2 
STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF A GLUTATHIONE S-
TRANSFERASE FROM TETRANYCHUS URTICAE 
 
2.1 BACKGROUND AND INTRODUCTION 
Glutathione S-transferases (GSTs) are present in several trees of life (both 
prokaryotic and eukaryotic) and serve to protect cells from oxidative stress, endogenous 
toxins, organophosphates, organotins, carbamates, pyrethoids and other xenobiotics [2, 62, 
63]. The thiol group of reduced glutathione (GSH) is conjugated to an electrophilic 
compound to make an excretable, water soluble product; alternatively, glutathione can act 
as a co-factor such as in a dehydrochlorination reaction [62]. There are several 
classifications of GSTs which are based on their primary amino acid sequence [62]. In 
insects, the current classifications of GSTs known are delta, epsilon, mu, omega, sigma, 
theta and zeta [64, 65]. GST diversity is very common in insects which may be attributed 
to alternative gene splicing, genetic rearrangements and local gene duplications that can 
result in altered substrate specificity [62, 63]. Insect GSTs are responsible for the 
detoxification of several insecticides used in agriculture such as 1,1,1-trichloro-2,2-bis(4-
chlorophenyl)ethane (4,4’-DDT), chlorfenapyr and permethrin [2, 62]. Furthermore, in 
addition to gene modifications, some insect GSTs can be upregulated in the presence of 
insecticides and display slow turnover of the insecticide(s), effectively causing 
sequestration and broad-spectrum resistance [63].  
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Almost all GSTs form homodimers or heterodimers with two active sites [62, 66]. 
In one special case, however, a GST in Plasmodium falciparum has been shown to form a 
low GSH affinity tetramer but a high affinity homodimer in the presence of increased GSH 
concentration [67]. The active sites of GSTs consist of two subsites: G-site (formed by N-
terminal residues) and H-site (formed by C-terminal residues). The G-site consists of 
residues near the N-terminus and is responsible for binding GSH [66]. The main G-site 
residue involved with activating the reduced thiol of GSH can either be a cysteine, serine, 
threonine or tyrosine [66]. The H-site consists of residues near the C-terminus and binds 
hydrophobic compounds that are targets for GSH conjugation. 
 T. urticae is a polyphagous, worldwide agricultural pest that is rapidly developing 
insecticide resistance due to its rapid reproductive cycle and the widespread use of 
insecticides [2]. The growing insecticide resistance in T. urticae can be attributed to several 
cytochrome P450 and GST gene families [3]. Four GSTs from T. urticae have been 
characterized to date: TuGSTd10, TuGSTd14, TuGSTm09 [3] and TuGSTd05 [65]. The 
TuGSTd10, TuGSTd14 and TuGSTm09 enzymes exhibited affinity towards abamectin, an 
insecticide, and also peroxidase activity towards Cumene hydroperoxide [3]. TuGSTd05 
exhibited activity towards the de-esterified metabolite of cyflumetofen, a more recently 
introduced insecticide [65]. A delta-class GST (tetur01g02230) is studied here and was 
recombinantly expressed in E. coli. Several compounds were tested by UV-Vis 
spectroscopy to determine T. urticae GST (TuGST) specificity and some binding 
cooperativity was observed. Furthermore, structural elements of a predicted structure for 
TuGST and implications for cooperativity and substrate binding are explored. 
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2.2 EXPRESSION AND PURIFICATION OF TUGST IN PJEXPRESS411 
 Initially, TuGST (tetur01g02230) was ordered from DNA2.0 in the IPTG-inducible 
expression vector pJExpress411 with a T7 promoter. The gene was synthesized to contain 
an N-terminal cleavable 6xHis-tag for ease of purification with the TEV cut site 
MHHHHHHSSGVDLGTENLYFQ/SGSG where the cut site is shown with a slash. DNA 
was transformed into BL-21 (DE3) E. coli via heat shock and cells were plated on KAN 
(50 µg/mL) plates at 37ºC for 16 hours. For inoculation, 10 mL of starter culture was used 
in 1.0 L of LB containing 50 µg/mL KAN. Cultures were shaken at 37ºC until an OD of 
0.8 was reached and then cooled down to 16ºC for protein expression with 0.4 mM IPTG 
for 16 hours. Cell pellets were harvested by spinning cultures in a Beckman Coulter 
Ultracentrifuge (Indianapolis, IN) at 4ºC which were immediately frozen at -80ºC until 
needed further. 
 Pellets were resuspended in lysis buffer (50 mM Tris pH 7.4, 500 mM NaCl, 2% 
glycerol, 20 mM β-ME, 10 mM imidazole) using 5.0 mL buffer per gram of pellet and 
lysed by sonication using a Branson Sonifier 450. Cell lysate was spun down in a Beckman 
Coulter Ultracentrifuge (Indianapolis, IN) at 4ºC and supernatant was loaded onto a 5.0 
mL resin bed of ThermoFisher HisPur NiNTA Resin (Grand Island, NY) equilibrated in 
wash buffer (50 mM Tris pH 7.4, 500 mM NaCl, 2% glycerol, 20 mM β-ME, 30 mM 
imidazole). The column was washed several times with wash buffer and protein was eluted 
with elution buffer (50 mM Tris pH 7.4, 500 mM NaCl, 20 mM β-ME, 250 mM imidazole). 
Elutions were collected in 1.5 mL fractions and run on a 12% SDS-PAGE gel to determine 
fractions that contain protein. Elutions containing protein were put into ThermoFisher 
SnakeSkin Dialysis Tubing (Grand Island, NY) with a 3,000 MW cutoff and dialyzed in 
 31 
dialysis buffer (10 mM Tris pH 7.4, 150 mM NaCl, 5.0 mM β-ME) at 4ºC for 16 hours. 
 TuGST was concentrated using an EMD Millipore Amicon Ultra-15 concentrator 
(Billerica, MA) with a 3,000 MW cutoff, and concentration was determined by A280 using 
the molar extinction coefficient 50,880 M-1 cm-1 and MW 27,163 as determined by the 
ExPASy ProtParam tool [37]. Concentrated protein was put on a Superdex 200 SEC 
column attached to an ÄKTA Pure FPLC system (GE Healthcare, Marlborough, MA) 
equilibrated in FPLC buffer (10 mM Tris pH 7.4, 150 mM NaCl). Peaks corresponding to 
TuGST were pooled and the protein concentration was determined using the Bradford 
method [68]. To remove the N-terminal his-tag from TuGST, it was subjected to TEV 
protease cleavage. Briefly, pure TuGST (1-2 mg/mL) was incubated with TEV protease in 
a 1:100 (w/w) protease/protein ratio and dialyzed for 12 hours in dialysis buffer at 4˚C. 
After cleavage, TuGST was loaded onto an NiNTA column equilibrated in FPLC buffer 
and TuGST was collected in the flow through and concentrated. Due to poor yields and 
instability of TuGST, fusion partners for protein expression and a tagless construct were 
pursued. 
2.3 CLONING TUGST INTO PMCSG28, PMCSG29 AND PMBPCS1 
 
pMCSG28 and pMCSG29 Cloning 
  
 Purification of TuGST with N-terminal his-tag resulted in very poor yields of 
protein (around 3.0 mg per liter culture). Furthermore, TEV his-tag cleavage resulted in 
most of the protein denaturing and the final yield of TuGST was less than one milligram 
(data not shown). To increase TuGST yield, expression options with fusion partner 
maltose-binding protein (MBP) were explored. Two plasmids, pMCSG29 (C-terminal 
MBP, C-terminal 6xHis-tag) and pMBPcs1 (N-terminal MBP, C-terminal 6xHis-tag) were 
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tested for their abilities to increase TuGST expression. An additional plasmid, pMCSG28, 
was also used to generate a tagless TuGST construct that contains no terminal His-tag or 
fusion partner. 
 The pMCSG28 and pMCSG29 plasmids were purchased from DNASU Plasmid 
Repository (Tempe, AZ). These vectors are designed to express protein with a C-terminal 
TEV-cleavable 6xHis-tag or N-terminal MBP, TVMV cut site, LIC site (gene insert), TEV 
cut site and 6xHis-tag, respectively; however, the reverse insertion primer for pMCSG28 
(pMCSG28-GST-R) was designed to include a stop codon on the insert so this vector could 
be used for tagless TuGST expression. The vectors were amplified at the LIC site to 
generate blunt ends for LIC using the primers pMCSG28/29-AMP-F and pMCSG28/29-R 
listed in Table 2.1; both pMCSG28 and pMCSG29 contain identical LIC sites so only one 
set of primers was needed to amplify both vectors. KOD polymerase (EMD Millipore, 
Billerica, MA) was used following the manufacturer’s protocol with the addition of 1.0 M 
betaine monohydrate. Thermalcycling was as follows: initial denaturation 95˚C for 2 
minutes, 30 cycles of 95˚C for 20 seconds, 61˚C for 10 seconds and 70˚C for 2 minutes 30 
seconds, followed by incubation at 4˚C. After PCR, the pMCSG28/29 products were 
purified by gel excision. 
 TuGST in pJExpress411 was used as base template for all reactions that involve 
amplifying the TuGST gene. The main sequence for TuGST was amplified with the 
primers pMCSG28/29-GST-F and pMCSG28-GST-R for pMCSG28 insertion, and 
primers pMCSG28/29-GST-F and pMCSG29-GST-R for pMCSG29 insertion listed in 
Table 2.1. Primers were designed to make the insert compatible with ligation independent 
cloning (LIC) into the target vectors. For pMCSG28 insert amplification, Phusion 
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polymerase (NEB) was used following the manufacturer’s protocol. Thermalcycling was 
as follows: initial 98ºC for 30 seconds, 35 cycles of 98ºC for 10 seconds, 61ºC for 15 
seconds, 72ºC for 10 seconds, a final extension at 72ºC for 30 seconds and an infinite hold 
at 12ºC. For pMCSG29 insert amplification, KOD polymerase (EMD Millipore, Billerica, 
MA) was used following the manufacturer’s protocol with the addition of 1.0 M betaine 
monohydrate. Thermalcycling was as follows: initial denaturation of 95˚C for 2 minutes, 
20 cycles of 95˚C for 20 seconds and 71˚C for 20 seconds, followed by incubation at 4˚C. 
All PCR products were purified by gel excision. 
Sticky ends for LIC were made by incubating gel excised PCR products with T4 
DNA polymerase (NEB, Ipswich, MA). A 40 µL reaction containing about 300 fmoles of 
vector (pMCSG28/29), 5.0 mM DTT, 2.5 mM dATP, 1X NEB2.1 buffer and 3.0 units of 
T4 DNA polymerase, and a 40 µL reaction containing about 1000 fmoles of insert, 5.0 mM 
DTT, 2.5 mM dTTP, 1X NEB2.1 buffer and 3.0 units of T4 DNA polymerase were 
incubated at room temperature for 30 minutes. The T4 DNA polymerase was then 
inactivated at 75ºC for 20 minutes and the reactions were mixed 10:10 at room temperature 
for 5 minutes. Next, 1.0 µL of 25 mM EDTA was added and the reaction was incubated 
another 5 minutes at room temperature. Transformation was performed with heat shock 
after adding the 20 µL LIC reaction to chemically competent DH5-α E. coli cells and plated 
on LB-AMP (50 µg/mL) plates at 37ºC for 16 hours. Clones were miniprepped with a 
GeneJET Plasmid Miniprep Kit (ThermoFisher, Grand Island, NY) and insertion of 
TuGST was first confirmed by restriction digest with XhoI following the manufacturer's 
instructions (NEB, Ipswich, MA). After restriction digest, clones with correctly sized 
fragments were sent to EtonBioscience (Research Triangle Park, NC) for sequencing with 
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T7 forward and T7 reverse primers. Correct clones were transformed via heat shock into 
chemically competent BL-21 (DE3) E. coli cells for protein expression. 
pMBPcs1 Cloning 
 
The construction of pMBPcs1 is described in Chapter 1.3 of this manuscript. 
TuGST was prepared for LIC into pMBPcs1 by using primers pMBPcs1-GST-F and 
pMBPcs1-GST-R listed in Table 2.1. For PCR, TuGST in pJExpress411 was used as 
template and the protocol for Phusion polymerase was followed (NEB, Ipswich, MA). The 
conditions for thermalcycling were as follows: initial 98ºC for 30 seconds, 35 cycles of 
98ºC for 10 seconds, 70ºC for 30 seconds, 72ºC for 25 seconds, a final extension at 72ºC 
for 1 minute and an infinite hold at 12ºC. PCR product was run on a 1.0% agarose gel and 
gel excised using a ThermoFisher GeneJET Gel Extraction Kit (Grand Island, NY) and 
eluted with sterile water. 
 Sticky ends for LIC were made by incubating gel excised PCR products with T4 
DNA polymerase (NEB, Ipswich, MA). A 40 µL reaction containing about 400 fmoles of 
pMBPcs1, 5.0 mM DTT, 2.5 mM dATP, 1X NEB2.1 buffer and 3.0 units of T4 DNA 
polymerase, and a 40 µL reaction containing about 1500 fmoles of TuGST, 5.0 mM DTT, 
2.5 mM dTTP, 1X NEB2.1 buffer and 3.0 units of T4 DNA polymerase were incubated at 
room temperature for 30 minutes. The T4 DNA polymerase was then inactivated at 75ºC 
for 20 minutes and the reactions were mixed 10:10 at room temperature for 5 minutes. 
Next, 1.0 µL of 25 mM EDTA was added and the reaction was incubated another 5 minutes 
at room temperature. Transformation was performed with heat shock after adding the 20 
µL LIC reaction to chemically competent DH5-α E. coli cells and plated on LB-AMP (50 
µg/mL) plates at 37ºC for 16 hours. Clones were miniprepped with a ThermoFisher 
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GeneJET Plasmid Miniprep Kit (Grand Island, NY) and insertion of TuGST was first 
confirmed by restriction digest with HindIII and XbaI following the manufacturer's 
instructions (NEB, Ipswich, MA). After restriction digest, clones with correctly sized 
fragments were sent to EtonBioscience (Research Triangle Park, NC) for sequencing with 
T7 forward and T7 reverse primers. Correct clones were transformed via heat shock into 
chemically competent BL-21 (DE3) E. coli cells for protein expression. 
2.4 TUGST EXPRESSION WITH PMCSG28, PMCSG29 AND PMBPCS1 
  
 Both fusion partner constructs (pMCSG29 and pMBPcs1) produced appreciable 
amounts of protein (around 20 mg per liter culture) after NiNTA and FPLC purifications, 
but using TEV protease to cleave 6xHis-tags would also result in most of the protein 
denaturing and yield less than one milligram of TuGST, similar to pJExpress411 
expression and purification (data not shown). However, purifying tagless TuGST 
(pMCSG28) resulted in considerable yields of active protein (about 15 mg per liter culture). 
 Purification and expression was the same as pJExpress411 up to the sonication. 
After sonication, lysate was dialyzed in 4.0 L of 25 mM Tris pH 7.5 at 4˚C for 12 hours. 
Next, the lysate loaded onto a HiPrep DEAE FF anion exchange column attached to an 
ÄKTA Pure FPLC system (GE Healthcare, Marlborough, MA) equilibrated in 25 mM Tris, 
pH 7.5. A stepwise elution gradient with sodium chloride was used in increments of 100 
mM up to 500 mM (data not shown). TuGST eluted off the column at 100 mM NaCl, was 
concentrated, then loaded onto a Superdex 200 SEC column attached to an ÄKTA Pure 
FPLC system (GE healthcare, Marlborough, MA) (Figure 2.1) equilibrated in 50 mM 
HEPES pH 8.0 and 150 mM NaCl. Final yield of protein was around 14 mg per liter culture. 
The FPLC results showed the correct size for monomeric TuGST, but the predicted 
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structure and kinetic results herein show that the protein is most likely homodimeric, as is 
most common for GSTs [3, 69–71]. Furthermore, purified TuGST was run both on SDS-
PAGE and Native-PAGE; SDS-PAGE showed one band at 24 kDa as expected, but the 
Native-PAGE showed the possibility of several oligomeric states (data not shown). 
2.5 TUGST KINETICS 
 
 All reagents mentioned here were purchased from Sigma-Aldrich (St. Louis, MO), 
Santa Cruz Biotechnology (Dallas, TX) or FisherScientific (Grand Island, NY). Data was 
fit using OriginPro software (Northampton, MA). Several compounds that are known 
targets of GSTs were tested which include GSH, 1-chloro-2,4,-dinitrobenzene (CDNB), 
1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane (4,4’-DDT), chlorfenapyr (CP), permethrin 
(PM), hydrogen peroxide, 1,2-epoxy-3-(4-nitrophenoxy)-propane (EPNP), 4-
nitrophenethyl bromide (4NPB), 4-nitrobenzyl chloride (4NBC), 4-hydroxynonenal 
(4HNE), ethacrynic acid (ECA) and 4-nitrophenyl acetate (4NPA)(Figure 2.2) by UV-Vis 
spectroscopy in a ThermoFisher NanoDrop 2000 and processed with NanoDrop 2000 
software (Grand Island, NY). The only compounds that seemed to exhibit any activity were 
GSH and CDNB as measured at 340 nm with a molar extinction coefficient of 9600 M-1 
cm-1 [64]. Reactions consisted of 10 mM GSH or 1.5 mM CDNB in 1.0 mL of 100 mM 
HEPES pH 8.0 with a working TuGST concentration of about 47 nM; TuGST showed the 
highest thermal stability in pH 8.0 buffer (data not shown). Reactions were performed in 
triplicate, and background GSH reactivity with target compounds was subtracted from 
reactions containing enzyme to determine the concentration of enzyme-conjugated GSH 
products. Interestingly, TuGST showed positive cooperativity towards GSH binding 
(Figure 2.3A) and negative cooperativity towards CDNB binding (Figure 2.3B). Kinetic 
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parameters are listed in Table 2.2. TuGST had a higher affinity for GSH than CDNB but a 
lower Vmax. The specific activity for both substrates was very low (around 15 
nmoles/min/mg of protein) relative to other GSTs [3, 64–66, 70, 72–75], and the kcat and 
catalytic efficiency for CDNB were about 2-fold higher than those for GSH.  
2.6 PREDICTED STRUCTURE OF TUGST 
 
 The structure for TuGST was predicted using the amino acid sequence for TuGST 
(Uniprot: T1JQ77) in the SWISS-MODEL online program [76–78]. The template model 
chosen was a silkworm delta-class GST from Bombyx mori (PDB code: 3VK9) with a 
43.7% sequence identity (Figure 2.4). The Global Model Quality Estimation (GMQE) was 
0.75 (range is from zero to one where one is more reliable predictions based on template 
used and sequence alignment). The residue range was 1 to 214 with 0.99 coverage. 
Measurements were made in COOT and structures made in PyMOL [79, 80]. 
 The predicted structure of TuGST is shown in Figure 2.5A. Similar to other GSTs, 
it is shown as a homodimer with two active sites. To observe potential substrate binding, 
the predicted TuGST model was aligned with a human theta-class GST, hGSTT2-2 (PDB 
code: 3LJR) (Figure 2.5A). Despite relatively low sequence identity (about 25%), aligning 
the structures of predicted TuGST and hGSTT2-2 had an RMSD value of 1.2 Å (performed 
in PyMOL [80]). Based on amino acid sequence TuGST appears to be a delta-class GST. 
Theta-class hGSTT2-2 was chosen for comparison for two reasons: 1) hGSTT2-2 has the 
ligand 1-menaphthyl glutathione conjugate bound which can be used as a homologous 
model for substrate binding, 2) Cooperativity has been observed in hGSTT2-2, and 
residues that may be the basis for this cooperativity are found in the predicted TuGST 
structure [66]. 
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 In hGSTT2-2, the residues Tyr73, Leu89 and Ala93 correspond to Tyr73, Val89 
and Ala93 in TuGST (Figure 2.5B) and may be responsible for cooperativity [66]. The 1-
menaphthyl glutathione conjugate is modeled in the active sites of TuGST. Residues in the 
G-site of TuGST include Ser11 (interacts with reduced thiol of GSH), His52, Ile54 (main 
chain backbone salt bridge), Glu66, Ser67 (main chain backbone salt bridge) and Arg68 
(Figure 2.5D) similar to those found in BmGST (3VK9 - Ser11, Gln51, His52, Glu66, 
Ser67 and Arg68 with a difference in only one residue (Gln51 in BmGST corresponds to 
Phe51 in TuGST) [81]; the Ile54 residue of BmGST could potentially form a salt bridge 
with 1-menaphthyl glutathione conjugate similar to that of TuGST. Furthermore, residues 
in the H-site potentially include Leu8, Tyr107, Phe115, Ile118 and Phe209 (Figure 2.5D) 
similar to Tyr107, Tyr115, Phe119, Phe206 and Ser212 found in BmGST [81]. The 
hydrophobic H-site residues in BmGST appear to be much bulkier than those found in 
TuGST which may contribute to their difference in specificities. 
2.7 DISCUSSION 
 The delta-class TuGST investigated here only had reactivity towards GSH and 
CDNB. Initially, expression and purification of an N-terminal 6xHis-tagged TuGST in E. 
coli lead to poor yields of protein, especially after cleaving the tag with TEV protease. The 
fusion partner MBP was also used and resulted in poor yields of TuGST. Only using a 
construct with no tags or fusion partners resulted in appreciable yields of TuGST. All 
constructs were tested for GST activity, and all of them except non-tagged TuGST 
displayed extremely deficient GST activity (relative to the non-tagged construct; data not 
shown). This observation may be explained by observing the predicted structure of TuGST. 
 For most GSTs, the N-terminal region contains residues responsible for binding 
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GSH, and the C-terminal region contains residues responsible for binding hydrophobic 
substrates. Adding a 6xHis-tag or fusion partner to either of the terminal ends may disrupt 
the protein active sites and overall protein folding, which is a possible explanation as to 
why these constructs had very poor GST activity or did not express well. Only after 
expressing TuGST with no tags or fusion partners was activity observed by UV-Vis 
spectroscopy. 
 Positive and negative cooperativity was observed for GSH and CDNB, 
respectively. For most GSTs, a lock-and-key motif (example hGSTP1-1, PDB code: 6GSS) 
is observed upon substrate binding, but an alternative “clasp” motif has been described in 
the middle of the subunit interface for some GSTs [66]. It has been speculated that the clasp 
motif behaves like two hands interlocking that may facilitate cooperativity [66]. Observing 
the predicted TuGST structure, the residues to form a clasp motif are present, but site-
directed mutagenesis experiments would need to be performed to confirm this type of motif 
and mechanism. Furthermore, negative cooperativity was observed in several GSTs upon 
binding the toxic nitric oxide adduct dinitrosyl-diglutathionyl iron complex (DNDGIC) 
[66]. The authors describe DNDGIC binding as a perturbation of normal enzymatic 
activity, and that cooperativity is displayed as a means of possible cooperative self-
preservation [66].  
 The negative cooperativity may help to maintain residual conjugating activity of 
GST against other endogenous toxins so complete GST activity is not lost [66]. A similar 
situation may be true for the TuGST studied here, although it did not show reactivity with 
almost any of the compounds tested. In this case, it is possible this TuGST may serve only 
sequester xenobiotics, which would effectively detoxify them, but more sensitive binding 
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studies and instrumentation such as Surface Plasmon Resonance (SPR) or Isothermal 
Titration Calorimetry (ITC) would provide more information on substrate binding than 
UV-Vis spectroscopy. 
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2.8 TABLES 
Table 2.1: Primers used for TuGST cloning. Nucleotides in bold are complementary to 
TuGST sequence. Lowercase letters are nucleotides insertions. 
 
Primer Name Primer Sequence
pMCSG28/29-GST-F 5' GTCTCTCCCATGGTCCTGGAGTTGTACCAACTGC 3'           
pMCSG28-GST-R 5' GGTTCTCCCCAGCGGGGCTCGAGTTACGCCAGA  3'
pMCSG29-GST-R 5' GGTTCTCCCCAGCCGCCAGACGTGCGCGCA 3'
pMCSG28/29-F 5' GGGGAGAACCTGTACTTCCAATCCGC 3'
pMCSG28/29-R 5' GGGAGAGACTCCTTCTTAAAGTTAAACAAA 3'
pMBPcs1-GST-F 5' TTCGGCTGCTATGGTCCTGGAGTTGTACCAACTGCCGATGAGCG 3'
pMBPcs1-GST-R 5' GGTTCTCCCCAGCCGCCAGACGTGCGCGCAGGAA 3'
pMBPcs1-F 5' CCTGAAAGACGCGCAGACTAATTCGgctgctGGGGA 3'
pMBPcs1-R 5' CGGATTGGAAGTACAGGTTCTCCCCagcagcCGAAT 3'
pMBPcs1-LIC-F 5' GGGGAGAACCTGTACTTCCAATCCGCCGGG 3'
pMBPcs1-LIC-R 5' agcagcCGAATTAGTCTGCGCGTCTTTCAG 3'  
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Table 2.2: Kinetic parameters for GSH and CDNB. All reactions were performed in 
triplicate. The measurement for specific activity was performed taking the average of three 
substrate concentrations performed in triplicate. Abbreviations: GSH – Reduced 
glutathione, CDNB – 2,4-dinitrochlorobenzene. 
Parameter GSH CDNB 
Wavelength (nm) 340 340 
Km (mM) 1.48 ± 0.05 1.74 ± 1.22 
Vmax (µM/sec) 1.28 ± 0.10 2.82 ± 0.62 
Hill Coefficient (n) 1.40 ± 0.10 0.58 ± 0.05 
Specific Activity 
(nmoles/min/mg) 
13.8 ± 6.6 15.5 ± 3.8 
kcat (sec-1) 27.2 60.0 
Catalytic efficiency (M-1 sec-1) 18.4 x 103 34.5 x 103 
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2.9 Figures 
 
 
Figure 2.1: Size exclusion results for purification of TuGST. Bio-Rad molecular weight 
standards (Hercules, CA) are shown (Ovalbumin and Myoglobin). 
 
  
 44 
 
 
Figure 2.2: Compounds tested with TuGST. GSH – reduced glutathione; CDNB - 1-
chloro-2,4-dinitrobenzene; 4,4’-DDT - 1,1,1-trichloro-2,2-bis(4-chlorophenyl) ethane; 
EPNP - 1,2-epoxy-3-(4-nitrophenoxy)-propane; 4NPB - 4-nitrophenethyl bromide; 4NBC 
- 4-nitrobenzyl chloride; 4NPA - 4-nitrophenyl acetate; 4HNE - 4-hydroxynonenal. Not 
shown: hydrogen peroxide. 
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Figure 2.3: Kinetic data for GSH and CDNB. Both data sets show Hill (red line) and 
Michaelis-Menten (M-M, blue dash) fits. A) UV-Vis spectroscopy with varied GSH 
displayed positive cooperativity. B) UV-Vis spectroscopy with varied CDNB displayed 
negative cooperativity. Both were fit using the Hill and Michaelis-Menten equations in 
OriginPro software (Northampton, MA). 
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Figure 2.4: Sequence alignment of TuGST and BmGST. TuGST and BmGST share a 
sequence identity of about 44%.  Residues highlighted in red are identical. Residues in red 
font are similar. Residues surrounded by a blue box represents similarity across groups of 
residues. Sequence alignment was performed with ESPript 3.0 [82]. 
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Figure 2.5: Predicted structure of TuGST. A) Structure alignment of predicted TuGST 
with hGSTT2-2 (PDB code: 3LJR). HGSTT2-2 is a homodimer and TuGST is predicted 
to be a homodimer. TuGST monomers are colored in shades of green and hGSTT2-2 are 
colored in shades of blue. The RMSD value from alignment was about 1.2 Å. B) 
Homologous model of TuGST (monomer 1 – green, monomer 2 – forest) with substrate 
analogue 1-menaphthyl glutathione conjugate (from 3LJR) modeled in the active sites. The 
N-terminal and C-terminal ends are colored in magenta and red, respectively. The red circle 
shows residues potentially involved in cooperative movement: Tyr73, Val89, Ala93 
(colored yellow for monomer 1 and cyan for monomer 2). C) Surface representation of 
TuGST that shows 1-menaphthyl glutathione conjugate buried in the active site. D) 
Different residues in the H and G sites of TuGST. Based on this predicted structure and the 
positioning of Ser11, TuGST is most likely a Ser-GST. 
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CHAPTER 3: 
 
STRUCTURAL CHARACTERIZATION OF AN INTRADIOL RING-CLEAVAGE 
DIOXYGENASE FROM TETRANYCHUS URTICAE 
 
3.1 BACKGROUND AND INTRODUCTION 
 Aromatic compounds are present throughout the environment, whether they are 
natural (such as the plant biopolymer lignin) or man-made contaminations (such as 
phthalates in papers, insecticides, cosmetics) [83, 84]. They are stabilized by their high 
resonance energy, thus making them very stable, and consequently, permit their persistence 
in the environment and sometimes contain electron-withdrawing groups that can further 
prevent their biodegradation [83, 84]. Their resistance to degradation is problematic as they 
can be stored in animal and plant tissues and accumulate to toxic levels [83]. 
 To combat some of these toxic aromatic compounds, many organisms (both 
prokaryotic and eukaryotic) are equipped with metalloproteins called dioxygenases that are 
capable of catabolizing aromatic compounds into non-toxic metabolites by utilizing a non-
heme iron in the active site [85, 86]. The genome of T. urticae includes a set of 17 genes 
encoding for secreted proteins that belong to the “intradiol dioxygenase-like” subgroup 
that may promote the T. urticae’s polyphagous lifestyle in detoxifying allelochemicals 
produced by plants [86]. Catechol, or 1,2-dihydroxy benzene, is a common metabolite 
found in plants which can be involved with many metabolic pathways [87] and act as 
substrate for intradiol ring-cleavage dioxygenases (ID-RCDs). Typically, ID-RCDs 
detoxify catechols (and catechol derivatives, i.e. substituted with halides, other functional
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groups) by cleaving the aromatic ring between C1 and C2, resulting in the formation of 
cis,cis-muconic acid (Figure 3.1) that can be further metabolized into succinate and acetyl-
CoA [84, 85]. In addition to allelochemical resistance, ID-RCDs may play a role in 
insecticide resistance as several insecticides are catechol-based such as carbofuran and 
propoxur (Figure 3.1) [88]. Tetur07g02040, a gene coding for a putative ID-RCD, is the 
only ID-RCD in the spidermite genome that contains introns [86] and is the focus of this 
research. Studying this protein has the potential to not only provide more information on 
the structural properties of ID-RCDs and their substrate specificities, but also could serve 
as a target for the development of new insecticides as the importance of this 
TuDioxygenase is not known. 
3.2 PROTEIN EXPRESSION AND PURIFICATION OF TUDIOXYGENASE 
 The gene for tetur07g02040 was ordered from DNA2.0 (Newark, California), 
codon optimized for E. coli and inserted into pJExpress411 with a T7 promoter, terminator 
and KAN resistance. Initially, the TuDioxygenase gene was ordered with the first 47 amino 
acids truncated for two reasons: 1) residues 1-22 were predicted to be a signal peptide 
(Uniprot reference number T1K8P1 [61], 2) residues 28-49 were predicted to be disordered 
[89]. Furthermore, the gene was synthesized to contain an N-terminal cleavable 6xHis-tag 
for ease of purification with the Tobacco Etch Virus (TEV) cut site 
MHHHHHHSSGVDLGTENLYFQ/SGSG where the cut site is shown with a slash. 
 Plasmid was transformed into BL-21 (DE3) cells by heat shock and grown in 1.0 L 
cultures of Luria-Broth (LB) with 50 µg/mL KAN or 100 µg/mL AMP shaking at 37˚C 
until an O.D. of 0.8 was reached. Cultures were cooled down to 16˚C and protein 
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expression was induced with 0.4 mM IPTG for 16 hours while shaking. Cells were pelleted 
and frozen at -80˚C until needed further. 
 For purification of TuDioxygenase, cell pellets were resuspended in lysis buffer (50 
mM Tris, 500 mM NaCl, 10 mM imidazole, 20 mM β-ME, 2% glycerol). After 
resuspension, cells were lysed by sonication with a Branson 45 Sonifier (ThermoFisher, 
Grand Island, NY). Crude extract was separated by spinning the lysate in a Beckman 
Coulter centrifuge with a JA-17 rotor at 16000 RPMs (Indianapolis, IN) for 25 minutes at 
4˚C. The clear, yellowish supernatant was poured into a 12 x 1.5 cm Bio-Rad column 
(Hercules, CA) filled with 5.0 mL of NiNTA resin (ThermoFisher, Grand Island, NY) 
previously equilibrated in wash buffer (50 mM Tris pH 7.4, 150 mM NaCl, 30 mM 
Imidazole, 2% glycerol, 20 mM β-ME) and then washed with wash buffer. Protein was 
eluted using elution buffer (50 mM Tris pH 7.4, 150 mM NaCl, 250 mM imidazole, 2% 
glycerol, 20 mM β-ME) and immediately put into dialysis buffer (10 mM Tris pH 7.4, 150 
mM NaCl) in ThermoFisher SnakeSkin Dialysis Tubing (Grand Island, NY) with a 10,000 
MW cutoff. Protein was dialyzed in dialysis buffer for 12 hours at 4˚C. 
 After dialysis, protein was concentrated with Amicon Ultra concentrators (EMD 
Millipore, Billerica, MA) with a 10,000 MW cutoff. Concentrated protein was put on a 
Superdex 200 column attached to an ÄKTA Pure FPLC system (GE Healthcare, 
Marlborough, MA) equilibrated in FPLC buffer (10 mM Tris pH 7.4, 150 mM NaCl). 
Peaks corresponding to TuDioxygenase were pooled and the protein concentration was 
determined using A280 with the MW 27068.39 Da and molar extinction coefficient 25,900 
M-1cm-1. Attempts at removing the his-tag resulted in heavy protein denaturation which is 
probably attributed to the instability of dioxygenase that was observed during purification. 
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Furthermore, purified TuDioxygenase was red in color, indicating the presence of non-
heme ferric iron, but the protein was very unstable and frequent red precipitate was 
observed in purified protein samples. Due to instability, the fusion partner MBP was 
pursued. 
3.3 MOLECULAR CLONING OF TUDIOXYGENASE INTO PMCSG29 AND PMBPCS1  
 The dioxygenase gene was cloned into pMCSG29 using ligation independent 
cloning (LIC). This plasmid is designed to generate a fusion protein as follows: protein of 
interest, TEV cut site, 6xHis-tag, TVMV cut site, MBP). Primers used for pMCSG29 cloning 
are listed in Table 3.1. The pJExpress411 vector containing dioxygenase was used as 
template for the first PCR with the primers p29-Dioxy-F and p29-Dioxy-R. PCR was 
performed using phusion polymerase following the manufacturer’s protocol (NEB, 
Ipswich, MA) and thermalcycling as follows: initial denaturation 98˚C 30 seconds, 30 
cycles of 98˚C for 10 seconds, 68˚C for 25 seconds and 72˚C for 25 seconds with a final 
extension at 72˚C for 5.0 minutes followed by an infinite hold at 12˚C. PCR product was 
purified using a GeneJet Gel Extraction Kit (ThermoFisher, Grand Island, NY). The 
pMCSG29 was amplified at the LIC site to generate blunt-ended vector with the primers 
pMCSG28/29-F and pMCSG28/29-R as mentioned in Chapter 2 with TuGST cloning. 
KOD polymerase (Millipore, Billerica, MA) was used following the manufacturer’s 
protocol with the addition of 1.0 M betaine monohydrate to amplify pMCSG29 by PCR. 
Thermalcycling was as follows: initial denaturation 95˚C for 2 minutes, 30 cycles of 95˚C 
for 20 seconds, 61˚C for 10 seconds and 70˚C for 2 minutes 30 seconds followed by an 
infinite hold at 12˚C. After PCR, product was purified by gel excision and cleaned up using 
a GeneJet Gel Extraction Kit (ThermoFisher, Grand Island, NY). 
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 Sticky ends for LIC were made by incubating gel excised PCR products with T4 
DNA polymerase (NEB, Ipswich, MA). A 40 µL reaction containing 170 fmoles of 
pMCSG29, 5.0 mM DTT, 2.5 mM dATP, 1X NEB2.1 buffer and 3.0 units of T4 DNA 
polymerase, and a 40 µL reaction containing 670 fmoles of dioxygenase insert, 5.0 mM 
DTT, 2.5 mM dTTP, 1X NEB2.1 buffer and 3.0 units of T4 DNA polymerase were 
incubated at room temperature for 30 minutes. The T4 DNA polymerase was then 
inactivated at 75ºC for 20 minutes and the reactions were mixed 10:10 at room temperature 
for 5.0 minutes. Next, 1.0 µL of 25 mM EDTA was added and the reaction was incubated 
another 5.0 minutes at room temperature. Transformation was performed with heat shock 
as mentioned previously after adding the 20 µL LIC reaction to the cells, and cells were 
plated on LB-AMP (50 µg/mL) plates at 37ºC for 16 hours. Clones were miniprepped with 
a GeneJET Plasmid Miniprep Kit (ThermoFisher, Grand Island, NY) and insertion of 
dioxygenase was first confirmed by restriction digest with XhoI following the 
manufacturer's instructions (NEB, Ipswich, MA). After restriction digest, clones with 
correctly sized fragments were sent to EtonBioscience (Research Triangle Park, NC) for 
sequencing with T7 forward and T7 reverse primers. Correct clones were transformed via 
heat shock into BL-21 (DE3) E. coli cells. 
Cloning TuDioxygenase into pMBPcs1.  
 The pMBPcs1 plasmid was generated and amplified as previously mentioned in 
Chapter 1 (Page 5). Dioxygenase insert was amplified using the primers pMBPcs1-Dioxy-
F and pMBPcs1-Dioxy-R shown in Table 3.1 and PCR performed using phusion 
polymerase following the manufacturer’s protocol (NEB, Ipswich, MA) with 
thermalcycling as follows: initial denaturation at 98˚C for 30 seconds, 35 cycles of 98˚C 
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for 10 seconds, 70˚C for 30 seconds and 72˚C for 25 seconds and a final extension of 72˚C 
for 5.0 minutes followed by an infinite hold at 12˚C. PCR product was purified using a 
GeneJET Gel Extraction Kit (ThermoFisher, Grand Island, NY). Sticky ends for LIC were 
made by incubating gel excised PCR products with T4 DNA polymerase (NEB, Ipswich, 
MA). A 40 µL reaction containing 600 fmoles of pMBPcs1, 5.0 mM DTT, 2.5 mM dATP, 
1X NEB2.1 buffer and 3.0 units of T4 DNA polymerase, and a 40 µL reaction containing 
1000 fmoles of dioxygenase insert, 5.0 mM DTT, 2.5 mM dTTP, 1X NEB2.1 buffer and 
3.0 units of T4 DNA polymerase were incubated at room temperature for 30 minutes. The 
T4 DNA polymerase was then inactivated at 75ºC for 20 minutes and the reactions were 
mixed 10:10 at room temperature for 5.0 minutes. Next, 1.0 µL of 25 mM EDTA was 
added and the reaction was incubated another 5.0 minutes at room temperature.  
 Transformation was performed with heat shock as mentioned previously after 
adding the 20 µL LIC reaction to the cells, and cells were plated on LB-AMP (50 µg/mL) 
plates at 37ºC for 16 hours. Clones were miniprepped with a GeneJET Plasmid Miniprep 
Kit (ThermoFisher, Grand Island, NY) and insertion of dioxygenase was first confirmed 
by restriction digest with HindIII and XbaI following the manufacturer's instructions (NEB, 
Ipswich, MA). After restriction digest, clones with correctly sized fragments were sent to 
EtonBioscience (Research Triangle Park, NC) for sequencing with T7 forward and T7 
reverse primers. Correct clones were transformed via heat shock into BL-21 (DE3) E. coli 
cells. 
3.4 EXPRESSION AND PURIFICATION OF DIOXYGENASE-MBP AND MBP-DIOXYGENASE 
 Dioxygenase-MBP and MBP-dioxygenase were transformed, expressed and 
purified in the same manner as TuDioxygenase but with 5.0 mM maltose in all purification 
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buffers. Tris and imidazole (50 mM) were used in dialysis and FPLC buffers. Dioxygenase-
MBP yielded decent amounts of protein (~10 mg/L culture); however, the protein did not 
have the red hue observed from TuDioxygenase purification that would indicate the 
presence of the non-heme iron (and most likely properly folded protein) so this construct 
was not pursued further. MBP-dioxygenase yielded decent quantities of protein (~12 mg/L 
culture) and had the desired red hue after purification. Protein yield was slightly increased 
by adding 3.0 mg of ferrous sulfate heptahydrate to the 1.0 L LB culture pre-induction and 
to the lysis buffer. Protein concentration of MBP-dioxygenase was determined using A280 
with the MW 67,027.82 Daltons and molar extinction coefficient 92,375 M-1cm-1 as 
determined by using ExPASy ProtParam tool [37]. Attempts were not made to remove the 
his-tag from MBP-dioxygenase due to instability observed from purification of 
TuDioxygenase 
3.5 CRYSTALLIZATION OF MBP-DIOXYGENASE 
 All chemicals were purchased from Hampton Research (Aliso Viejo, CA), 
ThermoFisher (Grand Island, NY) or Sigma-Aldrich (St. Louis, MO). Crystallization 
experiments were performed at room temperature using the sitting-drop vapor diffusion 
method and MRC 2-drop 96-well crystallization plates (Hampton Research, Aliso Viejo, 
CA). Initially, MBP-dioxygenase crystals were grown in 0.1 M sodium cacodylate 
trihydrate pH 6.5, 0.2 M magnesium acetate tetrahydrate, 20% w/v PEG8000 (3:1 of 
protein:mother liquor where protein ~13 mg/mL). These crystals were microseeded due to 
their small size and red color. For microseeding, crystals were crushed and resuspended in 
a 1.5 mL tube filled with 150 µL of the cacodylate crystallization solution and a glass bead 
then vortexed. An equal volume of MBP-dioxygenase (~13 mg/mL) was added to the seed 
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stock and drops were set with 1:1 ratio of protein to mother liquor as written above. Using 
the seed stock, red crystals grew after about one month in 0.1 M Tris pH 7.5, 15% w/v 
PEG6000. 
3.6 DATA COLLECTION, STRUCTURE DETERMINATION AND REFINEMENT OF 
TUDIOXYGENASE.   
  
 Table 3.2 shows the data collections statistics for the TuDioxygenase crystal 
structure mentioned here. The crystal structure for TuDioxygenase was deposited in the 
Protein Data Bank (PDB) with the accession code 5VG2. Crystals were cryo-cooled in 
liquid nitrogen and data was collected using Southeast Regional Collaborative Access 
Team (SER-CAT) 22ID beamline at the Advanced Photon Source (APS), Argonne 
National Lab (Argonne, IL). Data were processed with the HKL-2000 software package 
[41]. Molecular replacement was performed using MOLREP [42] integrated with HKL-
3000 [43] using the PDB model 4ILT for molecular replacement. BUCCANEER [44] and 
HKL-3000 were used to rebuild the initial model. Refinement was performed using 
REFMAC [46] and HKL-3000 [43]. Non-crystallographic symmetry was used during the 
whole process of refinement. TLS refinement was used during the last stages of refinement 
and the TLS Motion Determination server was used for partitioning protein chains into the 
rigid bodies undergoing vibrational motions [90, 47]. Model was updated and validated 
with COOT [48]. MOLPROBITY was used in the final steps of the model validation [49]. 
The final model together with structure factors were deposited to the Protein Data Bank. 
 The programs ProFunc [91] and PDBePISA [53] were used to analyze oligomeric 
assembly and secondary structure, bond measurements were performed in COOT [48] and 
structures were made using PyMOL [54] and UCSF-Chimera [92]. 
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3.7 CRYSTAL STRUCTURE OF MBP-DIOXYGENASE 
 Similar to the crystallization of MBP-cyanase (chapter 1), MBP was not present in 
the crystal structure of MBP-dioxygenase. TuDioxygenase crystallized in monoclinic 
system with four protein chains present in the asymmetric. In crystal TuDioxygenase 
appears to be monomeric which is consistent with size exclusion results (data not shown). 
The interface area between neighboring monomers is around 600 Å2 and 360 Å2. Each 
chain consists of residues 56-259 (with respect to complete dioxygenase gene sequence) 
where the first 8 amino acids (residues 48-55) of the truncated recombinant dioxygenase 
studied here are not visible in the electron density, nor is the TEV cut site and 6xHis-tag 
on the C-terminus. β-ME was used in some purification buffers, but each chain starts at 
Cys56 which forms a disulfide bridge with Cys99 on the same chain. There are six 
cacodylate ions present in the crystal structure: four cacodylate ions are coordinated by 
Lys106 and His175 for each chain, one cacodylate ion coordinated by Asn148 in chain C 
and one cacodylate ion that mediates some minor crystal contact between chains with 
Arg208 of chain A and Arg126 of chain C. 
 TuDioxygenase contains 7 β-sheets that form a β-sandwich and 6 α-helices. The β-
sandwich core is conserved with most intradiol-ring cleavage dioxygenases [93]. However, 
the conserved β-sandwich core usually consists of 8 β-sheets instead of 7, but the “missing” 
additional β-sheet is most likely in the truncated part of the dioxygenase (residues 23-47) 
as the N-terminal of truncated TuDioxygenase is located next to the β-sandwich (Figure 
3.2). The overall fold of dioxygenase is most similar to that of SACTE_2871 (PDB code: 
4ILT) from Streptomyces sp. SirexAA-E which was used as the starting model for 
molecular replacement [93]. There is only a 17% sequence identity but a 34% sequence 
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similarity between TuDioxygenase and SirexAA-E (Figure 3.3). Furthermore, 
TuDioxygenase has a similar ID-RCD domain to that of SACTE_2871 such that an 
entrance to the active site is a narrow cleft that is more solvent accessible than most other 
structurally similar ID-RCDs [93]. This cleft is mainly aligned with several ionizable 
amino acids. The intradiol dioxygenase domain consists of residues 64-189. 
3.8 COORDINATION OF ACTIVE SITE IRON 
 Metal binding sites were validated by the CheckMyMetal (CMM) server [94, 95]. 
The non-heme Fe+3 is coordinated by two tyrosines and two histidines in each active site: 
Tyr118, Tyr163, His169, His171 (Figure 3.4A). The ferric center is coordinated in a 
trigonal bipyramidal manner with the four active site residues and a water molecule which 
is common to ID-RCDs [96]. The water molecules (or OH- ions) are not shown as the 
corresponding electron density for them is of poor quality to allow for unambiguous 
modeling. Figure 3.4B demonstrates bidentate binding of catechol to the ferric center via 
the structural homologue PDB code: 3HHY, a 1,2-dioxygenase from the Gram-positive 
bacteria Rhodococcus opacus (shares 24% sequence identity with TuDioxygenase) [97]. 
Upon binding catechol, Tyr196 (Tyr163 in TuDioxygenase) is displaced from being 
equatorial to axial, and the trigonal bipyramidal binding is retained [85]. 
3.9 PUTATIVE MECHANISM OF TUDIOXYGENASE 
 Based on the mechanism of ID-RCDs and homologues in the PDB [84, 85, 93, 98], 
catechol binding displaces Tyr163 that permits bidentate binding to the active site iron [99] 
(Figure 3.4B). Cleaving an oxygen-oxygen (O2) bond generates an iron-bound oxide or 
hydroxide that acts as a nucleophile to hydrolyze the anhydride which is a result of Criegee 
rearrangement, ultimately generating the cis, cis-muconic acid product [99]. 
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3.10 DISCUSSION  
 Structural homologs of TuDioxygenase identified by the Dali server [51] were 
dioxygenases such as: SACTE_2871 (PDB code 4ILT, 153/155 residues aligned, RMSD 
1.8 Å); catechol 1,2-dioxygenase from Burkholderia multivorans (PDB code 5UMH, 
167/307 residues aligned, RMSD 2.4 Å); 3-chlorocatechol 1,2-dioxygenase from 
Rhodococcus Opacus 1Cp (PDB code 2BOY, 157/250 residues aligned, RMSD 2.1 Å); 
catechol 1,2-dioxygenase from Rhodococcus opacus 1Cp (PDB code 3HHY, 158/256 
residues aligned, RMSD 2.2 Å). No other structural homologues SACTE_2871 has a 
carbohydrate binding motif domain located on the C-terminal that appears to not be shared 
by the TuDioxygenase studied here [93]. However, similar to SACTE_2871, 
TuDioxygenase does not have an extensive N-terminal dimerization domain, an attribute 
common to ID-RCDs, as observed in the TuDioxygenase crystal structure [93].  
 Although the first 47 residues were truncated for this TuDioxygenase construct, the 
first 22 residues are predicted to be a signal peptide and most likely are not present in a 
mature form of the protein. The remaining 25 residues that are missing may facilitate 
oligomerization of TuDioxygenase, but further studies will need to be performed with the 
full-length protein. Most likely, the missing β-strand of the 7-strand β-sandwich is formed 
by these residues.
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3.11 TABLES 
Table 3.1: Primers used for TuDioxygenase cloning. 
Primer Sequence 
p29-Dioxy-F 5' GTCTCTCCCATGTCGTTTGTTACCCGTTTCACCGAGT 
p29-Dioxy-R 5' GGTTCTCCCCAGCGGCCCACATCAGATTGCT 
pMCSG28/29-F 5' GGGGAGAACCTGTACTTCCAATCCGC 
pMCSG28/29-R 5' GGGAGAGACTCCTTCTTAAAGTTAAACAAA 
pMBPcs1-Dioxy-F 5' TTCGGCTGCTAGTTCGTTTGTTACCCGTTTCACCGAG 
pMBPcs1-Dioxy-R 5' GGTTCTCCCCAGCGGCCCACATCAGATTGCTGC 
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Table 3.2: Data collection statistics for TuDioxygenase. Values in parentheses are for 
the highest resolution shell. 
 
 
  
PDB Accession code 5VG2
Diffraction source Synchrotron
Wavelength (Å) 1.000
a, b, c (Å) 60.48, 43.07, 165.72
α, β, γ (degrees) 90.0, 95.2, 90.0
Space group P 1 2 1
Solvent content (%) 39.89
Protein chains in AU 4
Resolution range (Å) 40.0-2.70
Highest resolution shell (Å) 2.75-2.70
Unique reflections 38010 (1906)
Redundancy 3.4 (3.5)
Completeness (%) 99.4 (100.0)
R merge 0.049 (0.281)
R pim 0.038 (0.194)
R rim 0.070 (0.366)
CC half 0.895
Average I/ σ(I ) 18.3 (3.9)
Rwork (%) 18.7 (26.5)
Rfree (%) 21.9 (27.9)
Mean B  value (Å
2
) 43.48
B from Wilson plot (Å
2
) 42.1
RMSD bond lengths (Å) 0.016
RMSD bond angles (degrees) 1.643
No. of amino acid residues A, B, C, U = 204
No. of water molecules 74
Most favored regions (%) 97.10
Additional allowed regions (%) 100.00
Refinement
Data collection
Ramachandran plot
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3.12 FIGURES 
 
 
Figure 3.1: The structure of catechol and catechol derivatives. The structure of 
catechol, the product of cleaving catechol via an intradiol ring-cleavage dioxygenase (cis, 
cis-Muconic acid) and two catechol-derived insecticides. 
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Figure 3.2: Crystal structure of TuDioxygenase. A) Cartoon representation of 
TuDioxygenase (PDB code: 5VG2). The β-sandwich core is conserved with most ID-
CRDs. The β-sandwich only consists of 7 β-strands which is different from the typical 8 β-
strands in ID-CRDs, but it is most likely attributed to the truncation of residues 1-47 of the 
recombinant TuDioxygenase studied here. The ferric center is shown by an orange sphere. 
The N-terminal is colored red and the C-terminal is colored blue. B) Surface representation 
of TuDioxygenase. Active site residues are colored in magenta and residues aligning the 
active site which form a narrow cleft are colored grey.
   
 
6
3
 
 
 
 
Figure 3.3: Sequence alignment of TuDioxygenase with SACTE_2871 homologue. Sequences are aligned without their respective 
signal peptides. Numbered residues are with respect to the sequence for TuDioxygenase. TuDioxygenase and SACTE_2871 (PDB code: 
4ILT) share a low sequence identity of 17% but a decent sequence similarity of 34%. Residues highlighted in red are identical and 
residues colored red are similar. Conserved secondary structure is shown by blue boxes. Active site residues are shown with greens 
arrows. Figure was made using ESPript 3.0 [82].
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Figure 3.4:  Active site of TuDioxygenase and a bacterial 1,2- dioxygenase homologue. 
A) Active site of TuDioxygenase. Two tyrosines (Tyr118, Tyr163), two histidines (His169, 
His171) and a water molecule (not shown) coordinate the active site iron in a trigonal 
bipyramidal manner. Both tyrosines are in equatorial positions when no substrate is bound. 
B)  Active site of 1,2-dioxygenase from Rhodococcus opacus (PDB code: 3HHY) which 
has a similar intradiol dioxygenase domain to TuDioxygenase. Upon binding catechol, 
Tyr196 (corresponds to Tyr163 of TuDioxygenase) is repositioned form equatorial to axial 
and the catechol binds in a bidentate manner. The water molecule bound to the ferric center 
is also displaced and the trigonal bipyramidal binding on the iron is retained [85]. 
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CHAPTER 4 
STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF 2-METHYLCITRATE 
SYNTHASE FROM ASPERGILLUS FUMIGATUS AND CITRATE SYNTHASE FROM 
HUMANS 
 
4.1 BACKGROUND AND INTRODUCTION 
 
Aspergillus fumigatus is a fungus that typically grows on compost and agricultural 
crops worldwide [4]. As part of its life cycle, A. fumigatus will form stress-tolerant, readily-
airborne spores in high capacity [100]. Consequently, this permits A. fumigatus to be one 
of the most prevalent airborne pathogens in the world [5, 101]. A. fumigatus is an 
opportunistic pathogen and spores are inhaled by humans on a frequent basis but normally 
eradicated from the body by the innate immune system neutrophils and macrophages [100, 
102]. However, inhalation of A. fumigatus spores by immunocompromised individuals can 
lead to invasive aspergillosis which has a mortality rate of 50-95% [4]. Individuals 
undergoing chemotherapy, organ transplants or that have chronic diseases such as 
tuberculosis, asthma or cystic fibrosis are especially more susceptible to invasive 
aspergillosis [4, 100]. Drugs currently used to treat A. fumigatus infections include azole 
compounds, polyenes and echinocandins, but resistance to these drugs is becoming more 
prevalent and new classes of anti-fungals are needed [100, 103–105].  
A new potential target for treating A. fumigatus infections is the metabolic enzyme 
2-methylcitrate synthase (mcsA) [5, 106, 107]. The mcsA enzyme catalyzes the primary 
step in the 2-methylcitrate synthase pathway which is specific to fungi (Figure 4.1) [5]. 
McsA performs a condensation reaction with oxaloacetate and propionyl-Coenzyme 
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(CoA), a toxic metabolite that is produced by leucine, methionine and valine breakdown, 
into 2-methylcitrate and non-toxic CoA-SH (Figure 4.2B)[5]. It has been shown that 
knocking out this enzyme greatly impairs growth and dissemination of A. fumigatus [5, 
107]. Furthermore, mcsA also has citrate synthase activity in which acetyl-CoA is used as 
co-substrate instead of propionyl-CoA to generate citrate from oxaloacetate [5]. 
In humans, propionyl-CoA is detoxified by converting it to methylmalonyl-CoA 
(via a carboxylation and isomerization reactions) which is then fed into the citric acid cycle 
(Figure 4.1) [5]. Although fungi and humans incorporate different metabolic cycles to 
detoxify propionyl-CoA, mcsA performs the same reaction as human citrate synthase 
(hCS), an enzyme part of the citric acid cycle (Figure 4.1, 4.2A). Moreover, mcsA and hCS 
share a 51% amino acid sequence identity which makes finding mcsA-specific inhibitors 
more challenging. Because of their similarities, mcsA and hCS were studied in parallel. 
Both enzymes had their crystal structures determined to observe any structural differences, 
and inhibitor efficacy was studied for both enzymes for the purpose of finding mcsA-
specific inhibitors. 
4.2 CLONING OF HCS INTO PMCSG53 
The plasmid HsCD00434245 containing the gene for hCS was purchased from 
DNASU [108–110], and the hCS gene (residues 29-466) was cloned into pMCSG53 
(DNASU) using ligation independent cloning (LIC). Briefly, hCS was amplified using the 
primers in Table 1 and the protocol for Phusion polymerase was followed (NEB, Ipswich, 
MA); for thermalcycling, an extension time of 30 seconds for 35 cycles was used with 100 
ng of template. Primers were designed to create complimentary 5’ and 3’ overhangs to 
pMCSG53 for LIC. The hCS insert was run on a 1.0% agarose gel and gel excised and 
purified using a ThermoFisher GeneJET Gel Excision Kit (Grand Island, NY). 
   
67 
Instead of cutting pMCSG53 with SmaI for LIC, pMCSG53 was amplified at the 
LIC site to generate blunt-ended 5’ and 3’ ends. To amplify pMCSG53, the primers 
pMCSG53-F and pMCSG53-R in Table 4.1 were used and the protocol for KOD 
polymerase was followed. For the KOD polymerase reaction, 4.0 µL of 25 mM magnesium 
sulfate and 10 µL of betaine monohydrate (5.0 M) with 10 ng of template were added in 
addition to other reagents listed in the manufacturer’s protocol (EMD Millipore, Billerica, 
MA). Thermalcycling was as follows: 95˚C for 2 minutes, 95˚C for 20 seconds, 10 second 
annealing at 61˚C, 2 minute extension at 70˚C for 25 cycles and a final extension at 70˚C 
for 10 minutes. After PCR, reactions were run on a 1.0% agarose gel and amplified 
pMCSG53 was gel excised and purified using a ThermoFisher GeneJET Gel Excision Kit 
(Grand Island, NY). 
 After amplification and purification of PCR products, the hCS insert and PCR-
amplified vector were prepared for LIC. For the insert, a 40 µL reaction of 8.5 µL insert 
(2,500 fmoles), 4.0 µL 10X T4 DNA polymerase buffer, 1.0 µL deoxycytidine triphosphate 
(dCTP; 100 uM), 2.0 µL DTT (100 mM), 23.5 µL diH2O and 1.0 µL T4 DNA polymerase 
(3.0 units). Vector was prepared in a 40 µL reaction containing 28 µL vector (620 fmoles), 
4.0 µL 10X T4 DNA polymerase buffer, 1.0 µL deoxyguanosine triphosphate (dGTP; 100 
uM), 2.0 µL DTT (100 mM), 4.0 µL diH2O and 1.0 µL of T4 DNA polymerase (3.0 units). 
Reactions were incubated at room temperature for 30 minutes and then T4 DNA 
polymerase was inactivated by heating at 75˚C for 20 minutes. After inactivation, 10 µL 
and insert and vector reactions were mixed together for 5 minutes at room temperature. 
Post-incubation, 1.0 µL of EDTA (25 mM) was added to the reaction and incubated for 5 
more minutes at room temperature. The entire reaction volume was transformed into 
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chemically competent DH5-α E. coli cells using heat shock at 42˚C for 45 seconds. Cells 
were plated on LB-Agar plates containing AMP (50 µg/mL) and grown at 37˚C overnight. 
Clones were inoculated into 5.0 mL LB containing AMP and grown at 37˚C overnight (16 
hours) with shaking. Minipreps were performed with a ThermoFisher GeneJET Plasmid 
Miniprep Kit (Grand Island, NY) following the manufacturer’s protocol and eluted with 
50 µL of nuclease-free water. Clones containing the hCS insert were first verified by setting 
up a restriction digest with NdeI and XhoI follow the manufacturer’s protocol (NEB, 
Ipswich, MA), and then sent to EtonBioscience (Research Triangle Park, NC) to confirm 
the correct sequence with T7 forward and T7 reverse primers. 
4.3 EXPRESSION AND PURIFICATION OF HCS AND MCSA 
 
Recombinant hCS and mcsA were truncated to residues 30-466 and 29-465, 
respectively, due to the presence of signal peptides at the N-terminus of these proteins; pig 
heart citrate synthase (pCS) was purchased as an ammonium sulfate suspension from 
Sigma-Aldrich (St. Louis, MO). The hCS-pMCSG53 plasmid was transformed into BL-21 
(DE3) pLysS cells due to the presence of rare E. coli codons in the hCS gene. The mcsA 
plasmid was ordered from DNA 2.0 (Newark, CA) in KAN-resistant vector pJExpress411 
and codon optimized for E. coli. Both plasmids operate under an IPTG inducible T7 
promoter and contain a cleavable N-terminal 6xhis-tag with TEV protease. Cells were 
grown to an O.D. of 0.8 at 37˚C with shaking and protein expression was induced with 0.4 
mM IPTG; cells were then cooled down to 16˚C, shaken overnight (12 hours), pelleted in 
a Beckman Coulter centrifuge (Indianapolis, IN) for 10 minutes at 4˚C and frozen at -80˚C 
until needed further. 
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 For purification, the hCS pellet was resuspended in lysis buffer (50 mM Tris, 500 
mM NaCl, 10 mM imidazole, 20 mM β-ME, 2% glycerol) and mcsA pellet was 
resuspended in mcsA buffer (50 mM Tris, 500 mM NaCl, 20 mM β-ME, 20% glycerol). 
The same buffers were used for both proteins for the remainder of the purification. After 
resuspension, cells were lysed by sonication with a Branson 45 Sonifier (ThermoFisher, 
Grand Island, NY). Crude extract was separated by spinning the lysate in a Beckman 
Coulter centrifuge (Indianapolis, IN) for 25 minutes at 4˚C. The clear, yellowish 
supernatant was poured into a 12 x 1.5 cm Bio-Rad column (Hercules, CA) filled with 5.0 
mL of NiNTA resin (ThermoFisher, Grand Island, NY) previously equilibrated in wash 
buffer (50 mM Tris pH 7.4, 150 mM NaCl, 30 mM Imidazole, 2% glycerol, 20 mM β-ME) 
and then washed with wash buffer. Protein was eluted using elution buffer (50 mM Tris pH 
7.4, 150 mM NaCl, 250 mM imidazole, 2% glycerol, 20 mM β-ME) and immediately put 
into dialysis buffer (10 mM Tris pH 7.4, 150 mM NaCl, 5 mM β-ME) in ThermoFisher 
SnakeSkin Dialysis Tubing (Grand Island, NY) with a 10,000 MW cutoff. Protein was 
dialyzed in dialysis buffer for 12 hours at 4˚C. 
 After dialysis, protein was concentrated with Amicon Ultra concentrators (EMD 
Millipore, Billerica, MA) with a 10,000 MW cutoff. Concentrated protein was put on a 
Superdex 200 column attached to an ÄKTA Pure FPLC system (GE Healthcare, 
Marlborough, MA) equilibrated in FPLC buffer (10 mM Tris pH 7.4, 150 mM NaCl). Peaks 
corresponding to either hCS or mcsA were pooled and the protein concentration was 
determined using the Bradford method [68]. To remove the N-terminal his-tag from mcsA, 
it was subjected to TEV protease cleavage. The hCS protein also contained a cleavable N-
terminal his-tag; however, TEV cleaves hCS at Ser166 so the his-tag could not be removed 
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from hCS. Briefly, pure mcsA (1-2 mg/mL) was incubated with TEV protease in a 1:100 
(w/w) protease/protein ratio and dialyzed for 12 hours in dialysis buffer.  After cleavage, 
mcsA was loaded onto an NiNTA column equilibrated in FPLC buffer and mcsA was 
collected in the flow through and concentrated. The mutant constructs, hCSA348G and 
mcsAG352A, were purified in the same manner as their wild type counterparts. 
4.4 DATA COLLECTION, STRUCTURE DETERMINATION AND REFINEMENT 
 
 Table 4.2 shows the data collections statistics for crystal structures mentioned here. 
All chemicals mentioned here were purchased as a screen from Hampton Research (Aliso 
Viejo, CA) or single chemicals from ThermoFisher (Grand Island, NY) or Sigma-Aldrich 
(St. Louis, MO). Ethyl-CoA was purchased from Jena Bioscience (Jena, Germany). 
Crystallization experiments for pCS, hCS, hCSA348G, mcsA and mcsAG352A were all 
performed at room temperature using the sitting-drop vapor diffusion method and MRC 2-
drop 96-well crystallization plates (Hampton Research, Aliso Viejo). Recombinant protein 
(around 4.0 mg/mL; 0.5 mg/mL for pCS) was mixed with mother liquor in a 1:1 ratio. 
Crystallization conditions for each structure in Table 4.2 are as follows: PDB code: 5UQO 
– 0.1 M Tris pH 8.5, 25% w/v PEG3350; PDB code: 5UQQ – 0.2 M sodium tartrate dibasic 
dihydrate pH 7.85, 20% w/v PEG3350; PDB code: 5UQR – 0.15 M DL-malic acid pH 7.0, 
20% w/v PEG3350 (co-crystallized with 1.0 mM ethyl-CoA and oxaloacetate); PDB code: 
5UQU – 0.2 M ammonium sulfate, 0.1 M Tris pH 8.5, 25% w/v PEG3350 (co-crystallized 
with 1.0 mM propionyl-CoA and oxaloacetate); PDB cod: 5UQ5 – 0.2 sodium tartrate pH 
7.85, 20% w/v PEG3350; PDB code: 5UZR – 0.2 M ammonium acetate pH 7.1, 20% w/v 
PEG3350; PDB code: 5UZQ – 0.1 M succinic acid pH 7.0, 12% w/v PEG3350 (co-
crystallized with 1.0 mM ethyl-CoA and oxaloacetate); PDB code: 5UZP – 0.2 M 
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ammonium acetate, 0.1 M sodium citrate tribasic dihydrate pH 5.6, 15% w/v PEG4000 
(co-crystallized with 1.0 mM propionyl-CoA and oxaloacetate). Cryo-protectant of 50% 
mineral oil with 50% paratone-N was only used for crystal structures 5UQQ, 5UQR, 5UQ5 
and 5UZR. 
Crystals were cryo-cooled in liquid nitrogen and data was collected using either 
Southeast Regional Collaborative Access Team (SER-CAT) 22BM, SER-CAT 22ID, 
Structural Biology Center (SBC) 19BM, SBC 19ID [111] or the Life Sciences 
Collaborative Access Team (LS-CAT) 21-ID-F or 21-ID-G beamlines at the Advanced 
Photon Source (APS), Argonne National Lab (Argonne, IL). Data were processed with the 
HKL-2000 software package [112]. Molecular replacement was performed using 
MOLREP [113, 114] integrated with HKL-3000 [43] using the PDB model 3ENJ as a 
starting model for 5UQO and 5UZR. The crystal structure of pCS with citrate and CoA-
SH bound (PDB code: 2CTS) was used as the starting model for holo-mcsA (5UQR). 
Refinement was performed using REFMAC [46] and HKL-3000 [43]. Non-
crystallographic symmetry was used during the whole process of refinement. TLS 
refinement was used during the last stages of refinement and the TLS Motion 
Determination server was used for partitioning protein chains into the rigid bodies 
undergoing vibrational motions [90, 115, 116]. Model was updated and validated with 
COOT [79]. MOLPROBITY was used in the final steps of the model validation [117]. The 
final models together with structure factors were deposited to the Protein Data Bank with 
accession numbers reported in Table 4.2. 
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The programs ProFunc [91] and PDBePISA [53] were used to analyze oligomeric 
assembly of the enzymes, bond measurements were performed in COOT and structures 
were made using PyMOL [80]. 
4.5 STRUCTURAL COMPARISON OF PCS AND CCS TO RECOMBINANT HCS 
 
 Citrate synthase from pig, chicken (cCS) and human all share very high amino acid 
sequence identity as follows: pCS and cCS – 93%, pCS and hCS – 96% and cCS and hCS 
– 92%. Figure 4.3 shows a sequence alignment between pCS, cCS and hCS, and Figure 4.4 
shows secondary structure conservation. Overall structure of hCS is similar to that of pCS 
and cCS with 19 alpha helices and four beta sheets (two parallel and two anti-parallel); 
helices 7, 13 and 17 are kinked at residues Ser179, Leu303 and His404 respectively, in 
these helices. Furthermore, pCS, cCS and hCS all form non-cooperative homodimers that 
contain two active sites where both monomers (~49 kDa each without signal peptide) 
contribute residues to both active sites (Figure 4.5A).  
 At the dimer interface are helices 6, 7, 11 and 12 from both chains that are anti-
parallel to one another; several electrostatic, van der Waals and hydrogen bonding 
interactions keep these helices sandwiched together with an interface area of about 6000 
Å2 (Figure 4.5B). In the active sites of hCS are two histidines (His265, His347 from chain 
A) and three arginines (Arg356, Arg428 from chain A and Arg448 from chain B) that are 
involved in binding oxaloacetate (Figure 4.5C). Several amine and carbonyl groups from 
peptide backbone form salt bridges and hydrogen bonds with the adenosine moiety of 
acetyl-CoA. A conserved Asn400 binds the carbonyl adjacent to the thiol group of acetyl-
CoA. Arg73 from chain A binds to P2 of CoA and Arg191 from chain B binds to the ribose 
sugar of CoA based on superimposition of hCS (PDB code: 5UZR) and cCS (PDB code: 
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4CSC) structure that contains bound D-malate and acetyl-CoA. Based on whether ligand 
is present, citrate synthases mentioned here can adopt “open,” “partially closed” or 
“closed” conformations which has been well-studied for pCS and cCS [118]; a hinge region 
for these conformational changes is located at His301 and Gly302 in hCS. 
4.6 MECHANISM FOR PCS, CCS AND HCS 
 
The mechanism of the condensation reaction for pCS and cCS has been well studied 
and characterized [118–122]. Substrates bind in an ordered mechanism where oxaloacetate 
binds first and increases enzyme affinity for acetyl-CoA by a factor of at least 20 [118]. 
Binding of oxaloacetate results in enzyme conformational change to “partially closed” and 
a binding site for acetyl-CoA is formed. It has been proposed that acid-base catalysis with 
His274 and Asp402 in the active site, respectively, promotes enolization of the thioester 
group on acetyl-CoA which is the rate-limiting step [118, 119]. A citryl-thioester 
intermediate is then formed with oxaloacetate via Claisen Condensation that is hydrolyzed 
most likely by water molecules trapped in the active site to generate the products citrate 
and CoA [118, 119]. Kinetic values obtained for recombinant his-tagged hCS purified here 
is comparable to that of pCS, cCS and hCS in literature [120, 121, 123] and are discussed 
later for mcsA comparison. 
4.7 COMPARISON OF HCS AND MCSA CRYSTAL STRUCTURES 
 
SECONDARY STRUCTURE CONSERVATION 
 
 The sequence identity shared between hCS (466 residues) and mcsA (465 residues) 
is 51% (Figure 4.3), and structure conservation is mapped between hCS and mcsA in Figure 
4.6. The apo structures of hCS (PDB code: 5UZR) and mcsA (PDB code: 5UQO) were 
superimposed in PyMOL with an RMSD value of 0.7 Å. Similar to other citrate synthases 
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mentioned here, mcsA forms a homodimer that adopts “open,” “partially closed” or 
“closed” conformations upon binding ligand; however, positive cooperativity was observed 
between active sites of mcsA based on kinetic results. Figure 4.7 shows space-filling 
models of apo-hCS (PDB code: 5UZR), apo-mcsA (PDB code: 5UQO), holo-cCS (PDB 
code: 4CSC - homologue) and holo-mcsA (PDB code: 5UQR). The conformational 
changes upon binding substrate is comparable for both hCS and mcsA. 
McsA has a total of four beta sheets (two parallel and two anti-parallel), but 21 
alpha helices compared to the 19 alpha helices found in hCS. At the C-terminal of helix 8 
in mcsA is Pro220 (corresponds to Asn219 in hCS helix 8) which causes the formation of 
additional helix 9. The other additional helix in mcsA, helix 17, is one turn and starts at 
Pro378. This residue corresponds to Pro372 in hCS; however, the residues of helix 17 in 
mcsA are more rigid and capable of forming peptide backbone hydrogen bonds whereas 
the corresponding residues in hCS form a partially flexible loop. Several helices are kinked 
in mcsA: helix 7 at Ser180, helix 8 at Tyr195 and helix 14 at Leu307. The main dimer 
interface of mcsA is an 8 anti-parallel alpha helix sandwich formed by helices 6, 7, 12 and 
13. Each active site of mcsA is similar to that of hCS and contains two histidines (His269 
and His351 from chain A) and three arginines (Arg360, Arg434 from chain A, Arg454 from 
chain B) that contribute to oxaloacetate binding (Figure 4.8). The binding of CoA for hCS 
and mcsA appears to be similar except for a difference of one residue: Arg191 in hCS (chain 
B) and Lys192 in mcsA (chain B). Lys192 forms a single salt bridge with the ribose sugar 
of CoA. Furthermore, upon adopting the “closed” conformation, trapped water molecules 
can be observed in the active site for both hCS and mcsA. 
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 The main dimer interface of mcsA is an 8 anti-parallel alpha helix sandwich formed 
by helices 6, 7, 12 and 13. The dimer interface area of mcsA was determined to be around 
5400 Å2 which is about 600 Å2 less than the dimer interface area hCS. Interestingly, when 
substrate is the bound, the dimer interface area increases to about 6200 Å2 for both hCS 
and mcsA. This significant increase of about 600 Å2 may contribute to the positive 
cooperativity observed for mcsA. The hinge region in mcsA is at His305 and Gly306. 
Although hCS and mcsA have similar “closed” conformations, several residues in hCS 
have greater movement with respect to corresponding residues in mcsA (Figure 4.9). Most 
of these residues are located near the active site or hinge region and move a greater distance 
(based on Cα’s) in hCS than they do in corresponding residues in mcsA. Based on these 
measurements, hCS specificity for only acetyl-CoA may be attributed to larger residue 
movements, which consequently may be forming a tighter “closed” conformation that 
cannot accommodate propionyl-CoA due to a more compact active site with respect to 
mcsA. 
4.8 COMPARISON OF HCS TO HCSA348G AND MCSA TO MCSAG352A 
 
 Measurements mentioned here were all performed in COOT (from Cα’s unless 
otherwise stated) [79]. Initially, apo-hCS (PDB code: 5UZR) and apo-mcsA (PDB code: 
5UQO) were compared to determine any differences in the active site which may explain 
why hCS has no 2-methylcitrate synthase activity with propionyl-CoA. The only difference 
observed in the active site was the presence of Ala348 in hCS and Gly352 in mcsA which 
are located near the CoA binding site (Figure 4.10) (for hCSA348G and mcsAG352A site-
directed mutagenesis, see section 4.14). 
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One crystal structure was obtained (PDB code: 5UZP) for hCSA348G in which 
oxaloacetate was bound in both active sites (Figure 4.11). Interestingly, the crystal structure 
does not show a “partially closed” conformation as is normal upon oxaloacetate binding 
(compared to pCS with oxaloacetate bound, PDB code: 4CTS) and formation of the acetyl-
CoA binding sight is not observed. In the hCSA348G crystal structure, active site residues 
Arg448 (chain B) and His347 (chain A) are not in their normal positions for oxaloacetate 
binding and resemble that of apo-hCS (Figure 4.5A). Upon oxaloacetate binding, His347 
moves about 3.7 Å towards oxaloacetate but it is not observed in the crystal structure for 
hCSA348G. Furthermore, based on 4CTS, hCS should form a salt bridge with both Glu266 
and oxaloacetate, but the positioning of Arg448 in hCSA348G only allows it to bind to 
oxaloacetate.  
No holo structures of hCS or hCSA348G were obtained from these studies; 
therefore, cCS with acetyl-CoA and D-malate bound (PDB code: 4CSC) will be used as a 
structural homologue for holo-hCS and conformational change discussion. In 4CSC, the 
methyl side chain of Ala321 (Ala348 in hCS) is about 3.4 Å from O4 of P2 in the adenosine 
moiety and the Cα is 3.3 Å. Although this may cause some steric clash, it does not explain 
how the A348G mutation hinders the “partially closed” conformational change. Comparing 
hCSA348G to apo-hCS and apo-pCS (PDB code: 4CTS), A348G displays some distortion 
in neighboring residues such as Val349 and Leu350 that could be inhibiting enzyme 
conformational changes. The hCSA348G mutant still displayed citrate synthase activity 
which is discussed further in the kinetics results. 
One crystal structure was obtained for mcsAG352A (PDB code: 5UQU) with 
oxaloacetate bound in one active site and a sulfate ion with CoA in the other (Figure 4.12). 
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The sulfate ion came from the crystallization condition and two other sulfates were bound 
on the surface of the protein. The G352A mutation did not seem to have an impact on 
positioning of active site residues and substrate binding which was observed by comparing 
apo-mcsA (PDB code: 5UQU) to holo-mcsA (PDB code: 5UQR). All active site residues 
involved in binding oxaloacetate and acetyl/propionyl-CoA substrates were bound to the 
sulfate ion and CoA, respectively, in their normal substrate binding orientations. Ala352 
shows little steric clash with CoA. The side chain methyl group of Ala352 is about 3.8 Å 
away from O4 of P2 in the adenosine moiety and the Cα is 3.4 Å which is slightly greater 
than wild type hCS. In apo-mcsA, Gly352 Cα is 3.3 Å from P2 and little difference in 
residue positioning is observed between Gly352 and G352A. Binding of either 
oxaloacetate only or the sulfate ion and CoA induced the “partially closed” or “closed” 
confirmations, respectively, that are observed for holo-mcsA. Comparing the structures of 
hCSA348G and mcsAG352A, only a disruption in the conformational change of 
hCSA348G was observed. Both mutants retained their native activities, and hCSA348G 
was not able to utilize propionyl-CoA as co-substrate. 
4.9 OTHER CRYSTAL STRUCTURES OF HCS AND MCSA 
 
 The apo-hCS 5UZQ crystal structure only contained one chain in the asymmetric 
unit. Two cysteines in the structure, Cys211 and Cys359, were modified to S, S-2 
(hydroxyethyl) thiocysteines (CME) molecules. Both apo-pCS (PDB code: 5UQ5) and 
apo-hCS (PDB code: 5UZR) have a chlorine ion bound in each active site. Apo-mcsA 
5UQQ crystal structure contains 6 chains in the asymmetric unit and has one tartrate 
molecule bound to Arg74 (chain B) and Lys456 (chain C). The tartrate molecule did not 
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cause significant conformational change except to Gly352 in which the Cα moves about 
5.3 Å away from the tartrate molecule. 
4.10 HCS, HCSA348G, MCSA AND MCSAG352A SUBSTRATE KINETICS 
 
All chemicals mentioned here were purchased from ThermoFisher (Grand Island, 
NY) or Sigma-Aldrich. Kinetic parameters for hCS, hCSA348G, mcsA and mcsAG352A 
are shown in Table 4.3 and were measured under pseudo-first order conditions by 
monitoring the reaction of the product CoA-SH with 5-5’-dinitrobenzoic acid (DTNB) [5]; 
the reaction of CoA-SH with DTNB produces 2-nitro-5-thiobenzoate (TNB) that absorbs 
at 412 nm with a molar extinction coefficient of 14,150 M-1 cm-1. Measurements were 
performed by using a ThermoScientific Nanodrop 2000 Spectrophotometer (Grand Island, 
NY) using a 1.0 cm path length. Reaction volumes were a total of 1.0 mL and contained 
100 mM Tris pH 8.0, 1.0 mM DTNB and 40 µM oxaloacetate and 40 µM acetyl-CoA for 
hCS; the same reaction volumes were used for mcsA except with 30 µM oxaloacetate and 
30 µM acetyl or propionyl-CoA. Enzyme was added last to each reaction. The enzyme 
working concentrations were 2.5 nM hCS, 6.15 nM hCSA348G, 22.6 nM mcsA or 50.8 
nM mcsAG352A; for inhibitor studies, concentrations of substrates were increased to 50 
µM and 40 µM for hCS and mcsA, respectively. After addition of enzyme to the reaction, 
the cuvette was mixed by inversion and immediately the A412 was measured. All reactions 
were performed in triplicate. Slope values were calculated using ThermoFisher Nanodrop 
2000 software (Grand Island, NY). Data was further processed using OriginPro software 
(Northampton, MA). The Michaelis-Menten equation was used to fit hCS and hCSA348G 
data, and the Hill coefficient was calculated using the Hill equation; the Hill equation was 
used for mcsA and mcsAG352A data (Figure 4.13). 
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OXALOACETATE BINDING 
 
 hCS had higher Km for oxaloacetate than hCSA348G but a lower Vmax. McsA had 
lower Km for oxaloacetate than mcsAG352A but a higher Vmax. The cooperativity displayed 
by hCS towards oxaloacetate was n = 1 (Hill coefficient) which indicates no cooperativity, 
and n values for mcsA and mcsAG352A were above one indicating positive cooperativity. 
The turnover number for hCS (208 sec-1) and mcsA (29.2) was greater than hCSA348G 
(111 sec-1) and mcsAG352A (11.2 sec-1), respectively. The catalytic efficiency of hCS (5.9 
x 107) and mcsA (6.0 x 106 sec-1 M-1) was greater than hCSA348G (1.9 x 107) and 
mcsAG352A (3.2 x 106), respectively. Comparing hCS and mcsA, hCS had higher Km, 
lower Vmax, higher kcat and higher catalytic efficiency than mcsA for oxaloacetate. 
ACETYL-COA BINDING 
 
 hCS had higher Km for acetyl-CoA than hCSA348G but a lower Vmax. McsA had 
lower Km for acetyl-CoA than mcsAG352A but a higher Vmax. The Hill coefficient of hCS 
towards acetyl-CoA was n = 1, but hCSA348G had a value of n = 0.85 ± 0.08 which 
indicates potential negative cooperativity. The Hill coefficient for mcsA and mcsAG352A 
were above one, where mcsAG352A seemed to display greater positive cooperativity with 
a value of n = 2.9. The turnover number for hCS (260 sec-1) and mcsA (32.7 sec-1) were 
greater than hCSA348G (117 sec-1) and mcsAG352A (10.4 sec-1), respectively. The 
catalytic efficiency of hCS (3.4 x 107 sec-1 M-1) and mcsA (6.6 x 106 sec-1 M-1) were greater 
than hCSA348G (1.1 x 107 sec-1 M-1) and mcsAG352A (2.9 x 106 sec-1 M-1), respectively. 
Comparing hCS and mcsA, had higher Km and Vmax for acetyl-CoA, but hCS had greater 
turnover and catalytic efficiency. 
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PROPIONYL-COA BINDING  
 
 2-methylcitrate synthase activity was not observed with using propionyl-CoA as 
co-substrate for hCS and hCSA348G. McsA had lower Km but higher Vmax for propionyl-
CoA than mcsAG352A. The Hill coefficient was above one for both mcsA and 
mcsAG352A. The turnover number (30.1 sec-1) and catalytic efficiency (6.5 x 106 sec-1 M-
1) of mcsA were both greater than mcsAG352A (12.2 sec-1 and 3.2 x 106 sec-1 M-1). 
4.11 SCREENING FOR INHIBITORS USING DIFFERENTIAL SCANNING FLUORIMETRY (DSF) 
 
 DSF is a high-throughput technique that measures protein stability via melting 
temperature (Tm) in the presence of different ligands [124, 125]. Briefly, protein (about 1.0 
mg/mL) was mixed 1000:1 with SYPRO-Orange dye (ThermoFisher Scientific, Grand 
Island, NY) in 50 mM Tris pH 8.0. Protein was set in a Bio-Rad Hardshell 96-well PCR 
plate (Hercules, CA) then covered with a Bio-Rad adhesive PCR plate seal. A Bio-Rad 
CFX96 Real-Time PCR machine (Hercules, CA) was used to measure SYRPO-Orange 
excitation at 488 nm and fluorescence resonance energy transfer (FRET). Reactions were 
started at 30˚C and increased to 90˚C in 2˚C increments every minute.  Protein Tm in the 
presence of ligands was measured and compared to protein Tm without any ligands present. 
Data was processed with Bio-Rad CFX Manager software (Hercules, CA). Reactions with 
substrates and products were performed in duplicate. Reactions with other ligands were 
performed in triplicate.  
Initially, inhibitor screening using this technique was validated by using 1.0 mM 
substrates and products as ligands (Table 4.4). As expected, all substrates and products 
increased thermal stability of hCS, hCSA348G, mcsA and mcsAG352A with the most 
dramatic increase in stability arising from incubation with oxaloacetate and oxaloacetate 
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with CoA-SH for all proteins. To find mcsA-specific inhibitors, ligands that only stabilize 
mcsA were tested further for their inhibitor efficacy via UV-Vis. Non-substrate/product 
compounds (1.0 mM) that were tested include 3-phosphonopropionic acid, 3,3-
thiodipropionic acid, dihydroxyfumaric acid, trimethylcitrate, DL-malic acid, maleic acid 
and hydroxycitrate (Figure 4.14). With the exception of trimethylcitrate, all of these ligands 
increased the stability of mcsA only. Trimethylcitrate did not increase the stability of either 
mcsA or hCS, but was still tested for inhibitory properties, along with the other ligands 
mentioned, with UV-Vis spectroscopy because it is a substrate analogue. 
4.12 TESTING INHIBITORS BY UV-VIS SPECTROSCOPY 
 
For inhibitor studies, inhibitors were used in three different concentrations and 
Lineweaver-Burk plots were used to calculate inhibitor constants (Ki). Ligands from DSF 
were tested for their efficacy against both substrates for each enzyme: oxaloacetate and 
acetyl-CoA for hCS; oxaloacetate and propionyl-CoA for mcsA. Inhibitor reactions were 
performed in 50 mM Tris pH 8.0, 1.0 mM DTNB in 1.0 mL total. The working 
concentration of enzyme for reactions was about 5.0 nM for hCS and about 36 nM for 
mcsA. Saturating concentrations of 50 µM oxaloacetate and acetyl-CoA were used for hCS 
reactions, and 40 µM oxaloacetate and propionyl-CoA used for mcsA reactions. Most 
inhibitors tested had their pH adjusted to around 8.0 and the pH of every reaction with 
inhibitor was checked to make sure inhibition was not due to pH change. The ligands 3-
phosphonopropionic acid, 3,3-thiodipropionic acid, dihydroxyfumaric acid, 
trimethylcitrate, DL-malic acid and maleic acid were used in concentrations of 20 mM, 40 
mM and 70 mM; trimethylcitrate did not increase thermal stability of hCS or mcsA, but it 
was still tested because it is a substrate analogue. Hydroxycitrate was tested in 
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concentrations of 8.0 mM, 16 mM and 24 mM. Lineweaver-Burk plots for each ligand are 
shown in Figure 4.15. A summary of inhibitor constants and type of inhibition displayed 
towards each substrate is shown in Table 4.5. 
 All the inhibitors tested had Ki values in the low millimolar range except 
trimethylcitrate. Trimethylcitrate had a Ki around 300 mM or higher for both hCS and 
mcsA (data not shown). The most mcsA-specific inhibitor was dihydroxyfumaric acid (a 
derivative of fumarate – a precursor in both the citric acid cycle and 2-methylcitrate cycle 
(Figure 4.1) in which variable oxaloacetate showed mixed inhibition (Kia = 23.6 mM, Kib 
= 90.6 mM) and variable propionyl-CoA showed competitive inhibition (Ki = 17.1 mM) 
(Figure 4.15 N, P); for hCS, dihydroxyfumaric acid had competitive inhibition with 
oxaloacetate (Ki = 90.5 mM) and acetyl-CoA (Ki = 73.0 mM). The best inhibitor of hCS 
was malic acid, another precursor in both the citric acid cycle and 2-methylcitrate cycle. 
Malic acid had mixed inhibition with both oxaloacetate (Kia = 14.2 mM, Kib = 169.3 mM) 
and acetyl-CoA (Kia = 6.5 mM, Kib = 19.3 mM) for hCS (Figure 4.15 Q, S); malic acid was 
noncompetitive with both oxaloacetate (Ki = 67.5 mM) and propionyl-CoA (Ki = 62.1 mM) 
for mcsA. Hydroxycitrate, a product analogue, inhibited both hCS and mcsA almost 
equally for both of their respective substrates (Figure 4.15 I - L). Interestingly, competitive 
inhibition with oxaloacetate (Ki = 8.0 mM) and acetyl-CoA (Ki = 14.6 mM) was observed 
for hCS, and noncompetitive inhibition with oxaloacetate (Ki = 16.6 mM) and competitive 
inhibition with propionyl-CoA (Ki = 6.9 mM) for mcsA.  
 Maleic acid, a substrate analogue of fumarate, had stronger inhibition of hCS than 
mcsA. It showed mixed inhibition with both oxaloacetate (Kia = 20.0 mM, Kib = 116.4 mM) 
and acetyl-CoA (Kia = 17.5 mM, Kib = 75.2 mM) for hCS which contrasts to the competitive 
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inhibition with oxaloacetate (Ki = 30.9 mM) and noncompetitive inhibition with propionyl 
CoA (Ki = 97.3 mM) for mcsA. The 3,3-thiodipropionic acid showed competitive 
inhibition for the substrates of both enzymes, but the inhibition of hCS (Ki = ~22 mM) was 
better than that of mcsA (Ki = ~50 mM) (Figure 4.15 E - H). Lastly, 3-
phosphonodipropionic acid was a better inhibitor with acetyl-CoA for hCS than propionyl-
CoA for mcsA, but a better inhibitor of oxaloacetate for mcsA than hCS (Figure 4.15 A - 
D). It had competitive inhibition with oxaloacetate (Ki = 71.7 mM) and acetyl-CoA (Ki = 
21.2 mM) for hCS, and mixed inhibition with oxaloacetate (Kia = 34.4 mM, Kib = 193.4 
mM and competitive inhibition with propionyl-CoA (Ki = 23.1 mM) for mcsA.  
Propionyl-CoA was also used to determine the inhibitor constant with oxaloacetate 
and acetyl-CoA for hCS. Concentrations of 60 µM, 80 µM and 120 µM propionyl-CoA 
were used. With these concentrations, mixed inhibition was seen with acetyl-CoA (Kia = 
~47 µM, Kib = ~170 µM) (data not shown). The inhibition of propionyl-CoA for 
oxaloacetate showed almost no inhibition at propionyl-CoA concentrations of 60 µM and 
80 µM (data not shown); 120 µM propionyl-CoA displayed weak inhibition with 
oxaloacetate (data not shown). 
4.13 DISCUSSION 
 
 A. fumigatus is a problem worldwide in both agriculture and healthcare, and new 
protein targets are needed. The protein characterized here, mcsA, has had its crystal 
structure determined along with hCS, an important enzyme in the citric acid cycle, to note 
any differences in these 51% sequence identical enzymes. Although their sequence identity 
is high, it is not known how mcsA can utilize both acetyl-CoA and propionyl-CoA as co-
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substrates whereas hCS is limited to only acetyl-CoA. Both hCS and mcsA form 
homodimers with two active sites and share nearly identical active site residues.  
Upon binding oxaloacetate, both hCS and mcsA undergo a conformational change 
from an “open” state to a “partially closed” state in which the binding site for either acetyl-
CoA or propionyl-CoA is formed. With both substrates bound, the enzymes form a “closed” 
state in which the active site becomes inaccessible to solvent as observed by our structures 
here and current structures for citrate synthase in the PDB. The residues Ala348 in hCS and 
Gly352 in mcsA were one main difference observed in the active site, and these residues 
were mutated and had their crystal structure determined with and without substrates. 
Although the G352A mutation in mcsA did not appear to have a significant impact on 
substrate binding and conformational change, the A348G mutation in hCS was much more 
pronounced. This mutation appeared to hinder the “partially closed” conformational state 
as observed by the crystal structure for hCSA348G with oxaloacetate bound in both active 
sites (PDB code: 5UZP). Furthermore, investigating individual residue movements from 
apo-hCS and apo-mcsA to holo-hCS and holo-mcsA structures showed that residues in hCS 
move a greater distance (based on Cα’s) than those of mcsA, which may imply that hCS 
forms a tighter “closed” conformation that may permit substrate specificity for acetyl-CoA 
only.  
The mechanism of the condensation reaction with acetyl-CoA and propionyl-CoA 
was not elucidated for mcsA. However, being that the active site of mcsA contains identical 
residues to that of citrate synthase, it is a good assumption that it would be very similar to 
the mechanism of citrate synthase [118, 119, 122, 126]. Most likely, either a citryl-CoA 
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intermediate or 2-methylcitryl-CoA intermediate is formed based on the presence of either 
acetyl-CoA or propionyl-CoA, respectively. 
Kinetic parameters of hCS, hCSA348G, mcsA and mcsAG352A were determined 
with DTNB and UV-Vis spectroscopy. Both mutants had lower turnover numbers and 
catalytic efficiency than their respective wild type counterparts. Overall, hCS had a higher 
kcat by a factor of about 8 and higher catalytic efficiency by about 10 for substrates than 
mcsA. Furthermore, mcsA displayed positive cooperativity whereas hCS did not display 
any type of cooperativity. 
To screen for potential inhibitors, the high throughput technique DSF was used. 
Seven compounds were tested for their inhibitory properties: 3-phosphonopropionic acid, 
3,3-thiodipropionic acid, potassium hydroxycitrate, dihydroxyfumaric acid, DL-malic 
acid, maleic acid and trimethylcitrate. Trimethylcitrate showed very poor inhibition of both 
hCS and mcsA at concentrations of 70 mM. None of these compounds showed an increase 
in protein stability for hCS based on DSF results, but they were still capable of inhibiting 
hCS, and in some cases, inhibited hCS better than mcsA (i.e. DL-malic acid and maleic 
acid). Although DSF allows the rapid screening of hundreds of compounds, it is apparent 
that the ligands used do not necessarily need to show an increase in protein thermal stability 
to serve as an inhibitor. Furthermore, the increase in protein thermal stability does not 
necessarily reflect how potent an inhibitor will be. For example, 3-phosphonopropionic 
acid showed a Tm increase of 6˚C degrees whereas dihydroxyfumaric acid displayed a 1˚C 
increase. However, based on inhibitor results, dihydroxyfumaric acid turned out to be a 
better inhibitor of mcsA than 3-phosphonopropionic acid. 
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All the inhibitors screened here showed either competitive, noncompetitive or 
mixed inhibition with respect to hCS and mcsA substrates. In most cases, hCS and mcsA 
were not subject to the same type of inhibition by the same inhibitor. For example, hCS 
displayed mixed inhibition with maleic acid for both oxaloacetate and acetyl-CoA, whereas 
competitive and noncompetitive inhibition was observed for oxaloacetate and propionyl-
CoA, respectively, for mcsA. The best inhibitor of mcsA was dihydroxyfumaric acid which 
is an analogue of fumarate. This compound inhibited hCS poorly in comparison to mcsA. 
Based on this result, it would be logical to try derivatives of compounds found in the 2-
methylcitrate cycle and the citric acid cycle to determine their inhibitor efficacy of mcsA 
and hCS. Currently, it is unclear why different types of inhibition are observed between 
hCS and mcsA for the same ligand, but it may be attributed to the tightness of the clamping 
motion from “open” to “closed” conformations of these enzymes. Co-crystallization of 
these inhibitors with hCS and mcsA may provide further insight as to why different types 
of inhibition are seen and potentially the development of mcsA-specific inhibitors based 
on these differences. 
4.14 SITE-DIRECTED MUTAGENESIS OF HCSA348G AND MCSAG352A 
 
Primers used for mutagenesis are listed in Table 3.1. The hCSA348G mutation was 
made using complimentary primers and the thermalcycling protocol for Phusion 
polymerase was followed (NEB, Ipswich, MA). Briefly, a 4 minute extension time was 
used for 25 cycles with 50 ng of template. For mcsAG352A, non-overlapping primers were 
designed with NEBquickchange using Q5 polymerase with the mutation in the forward 
primer (NEB, Ipswich, MA). Reaction conditions and thermalcycling used were based on 
the NEB Q5 polymerase protocol. Briefly, a 2 minute 45 second extension time was used 
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for 25 cycles with 1.0 ng of template. After hCS and mcsA PCR reactions, DpnI was added 
per the manufacturer’s protocol (NEB, Ipswich, MA) and incubated at 37˚C for 2 hours. 
Post-DpnI digest, reaction mixtures were transformed into chemically competent DH5-α 
E. coli cells and spread onto LB-Agar plates containing the appropriate antibiotic.  
Plates were incubated at 37˚C overnight. Clones were inoculated into 5.0 mL LB 
containing the appropriate antibiotic and grown at 37˚C overnight (about 16 hours) with 
shaking. Minipreps were performed with a ThermoFisher GeneJET Plasmid Miniprep Kit 
(Grand Island, NY) following the manufacturer’s protocol and eluted with 50 µL of 
nuclease-free water. Clones were sent to EtonBioscience (Research Triangle Park, NC) for 
sequencing with T7 forward and T7 reverse primers. When the point mutations were 
confirmed, the correct mutant plasmids were transformed into BL-21 (DE3) pLysS E. coli 
cells for hCSA348G and BL-21 (DE3) E. coli cells for mcsAG352A via heat shock at 42˚C 
for 45 seconds. Mutants were purified in the same manner as wild type. 
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4.15 TABLES 
 
Table 4.1: Primers used for hCS and mcsA cloning and mutagenesis. 
 
Primer Sequence 
pMCSG53-hCS-F 5' TACTTCCAATCCAATGCCTCCTCCACGAATTTGAAAGACATATTGG 3’ 
pMCSG53-hCS-R 5’ TTATCCACTTCCAATGTTACCCTGACTTAGAGTCCACAAACTTCAT 3’ 
pMCSG53-F 5’ATTGGAAGTGGATAACGGATCCGAATTCGA 3' 
pMCSG53-R 5’ ATTGGATTGGAAGTACAGGTTCTCGGTAC 3' 
hCSA348G-F 5’ CCAGGCTATGGCCATGGAGTACTAAGGAAGACT 3’ 
hCSA348G-R 5’ AGTCTTCCTTAGTACTCCATGGCCATAGCCTGG 3’ 
mcsAG352A-F 5’ TACGGCCACGCTGTTCTGCGCAAAC 3’ 
mcsAG352A-R 5’ ACCCGGCACAACGCGACC 3’ 
 
 
  
 
8
9 
Table 4.2: Data collection statistics for hCS and mcsA crystal structures. Numbers in parentheses represent statistics from the highest 
resolution shell. Abbreviations: AU – Asymmetric Unit. 
 
Protein mcsA mcsA mcsA mcsAG352A pCS hCS Dimer hCS monomer hCSA348G
PDB Accession code 5UQO 5UQQ 5UQR 5UQU 5UQ5 5UZR 5UZQ 5UZP
a, b, c (Å) 60, 116, 153 82., 130, 261 69., 94, 124 70, 94, 123 58, 59, 74 58, 74, 60 76, 76, 198 58, 111, 74
α, β, γ (degrees) 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 99, 98, 117 62, 93, 80 90, 90, 90 90, 99, 90
Space group P212121 P212121 P212121 P212121 P1 P1 P4212 P1211
Solvent content (%) 56.25 49.24 41.93 42.38 45.73 47.29 58.98 49.60
Protein chains in AU 2 6 2 2 2 2 1 2
Resolution range (Å) 50.01-2.50 31.41-2.30 40.00-1.75 50.01-1.70 50.01-1.60 40.00-2.30 50.01-2.16 45.06-2.29
Highest resolution shell (Å) 2.54-2.50 2.33-2.30 1.78-1.75 1.73-1.70 1.63-1.60 2.34-2.30 2.19-2.15 2.34-2.30
Unique reflections 37351 (1814) 125981 (4770) 82446 (3801) 85824 (4534) 109748 (5428) 37732 (1924) 30789 (1500) 42042 (2123)
Redundancy 4.9 (4.7) 4.9 (4.8) 5.7 (3.9) 7.8 (7.9) 2.2 (2.2) 2.1 (2.1) 8.5 (8.5) 3.7 (3.7)
Completeness (%) 94.8 (92.4) 99.7 (99.7) 98.0 (91.6) 94.2 (100.0) 96.9 (94.9) 96.5 (97.7) 94.1 (93.6) 100 (100)
R merge 0.066 (0.590) 0.081 (0.528) 0.078 (0.529) 0.062 (0.799) 0.061 (0.344) 0.078 (0.375) 0.068 (0.323) 0.123 (0.628)
R pim 0.044 (0.318) 0.052 (0.354) 0.041 (0.303) 0.029 (0.278) 0.046 (0.359) 0.083 (0.372) 0.029 (0.148) 0.082 (0.403)
R rim 0.104 (0.724) 0.117 (0.777) 0.104 (0.634) 0.081 (0.785) 0.068 (0.530) 0.123 (0.548) 0.094 (0.483) 0.159 (0.780)
CC half 0.806 0.809 0.722 0.857 0.733 0.776 0.968 0.750
Average I/ σ(I ) 21.1 (2.04) 18.4 (2.35) 16.4 (2.33) 35.2 (3.28) 19.95 (2.17) 10.3 (2.18) 25.87 (3.29) 11.57 (2.5)
Rwork (%) 19.1 (30.3) 18.5 (25.8) 13.48 (20.9) 15.84 (20.8) 15.25 (24.0) 17.02 (22.8) 19.60 (27.4) 15.59 (21.3)
Rfree (%) 23.3 (36.6) 21.4 (28.1) 17.48 (27.0) 19.21 (24.3) 17.84 (24.8) 21.45 (30.8) 23.23 (33.6) 20.55 (29.1)
Mean B  value (Å
2
) 57.96 42.98 16.92 27.60 20.65 26.66 53.62 28.05
B from Wilson plot (Å
2
) 56.90 42.20 17.90 27.70 21.29 26.32 52.37 27.63
RMSD bond lengths (Å) 0.012 0.012 0.018 0.015 0.013 0.013 0.011 0.014
RMSD bond angles (degrees) 1.6 1.5 1.8 1.7 1.6 1.6 1.5 1.6
No. of amino acid residues A, B = 434
A,F = 435; B = 
436; C = 437; 
D,E = 434
A = 439; B = 435A = 438; B = 436 A,C = 434 A = 434; D = 435 A = 434 A,B = 436
No. of water molecules 100 1449 1288 749 1058 400 159 576
Most favored regions (%) 98.30 98 98.9 98.5 99 98.3 98.4 99
Additional allowed regions (%) 100.00 99.8 100 100 100 100 100 100
Data collection
Ramachandran plot
Refinement
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Table 4.3: Kinetic parameters of hCS, hCSA348G, mcsA and mcsAG352A determined by UV-Vis spectroscopy. Abbreviations: 
OAA – Oxaloacetate, A-CoA – Acetyl-CoA, P-CoA – Propionyl-CoA. 
 
Kinetic  
Parameter 
hCS hCSA348G mcsA mcsAG352A 
OAA A-CoA 
P-
CoA 
OAA A-CoA P-CoA OAA A-CoA P-CoA OAA A-CoA P-CoA 
Km (µM) 3.6 ± 0.2 7.7 ± 0.6 n/a 5.7 ± 0.5 10.4 ± 1.5 n/a 4.9 ± 0.2 5.0 ± 1.3 4.7 ± 0.3 3.5 ± 0.3 3.6 ± 0.3 3.9 ± 0.1 
Vmax (µM/sec) 0.52 ± 0.01 0.65 ± 0.02 n/a 0.68 ± 0.02 0.7 ± 0.1 n/a 0.66 ± 0.02 0.7 ± 0.1 0.68 ± 0.03 0.57 ± 0.03 0.53 ± 0.04 0.62 ± 0.01 
Hill Coefficient 
(n) 
0.9 ± 0.1 0.9 ± 0.1 n/a 1.0 ± 0.1 0.9 ± 0.1 n/a 1.5 ± 0.1 1.6 ± 0.3 1.5 ± 0.1 1.8 ± 0.3 2.9 ± 0.5 1.7 ± 0.1 
kcat (sec-1) 208 260 n/a 111 117 n/a 29.2 32.7 30.1 11.2 10.4 12.2 
Kcat/Km (sec
-1M-1) 5.9 x 107 3.4 x 107 n/a 1.9 x 107 1.1 x 107 n/a 6.0 x 106 6.6 x 106 6.5 x 106 3.2 x 106 2.9 x 106 3.2 x 106 
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Table 4.4: Differential Scanning Fluorimetry (DSF) results using substrates as ligands. All substrates and products increased the 
thermal stability of hCS, hCSA348G, mcsA and mcsAG352A. 
 
 
Protein 
Increase in Melting Temperature Tm (˚C) 
Oxaloacetate 
Acetyl-
CoA 
Propionyl-
CoA 
Citrate 2-Methylcitrate CoA-SH 
Oxaloacetate + CoA-
SH 
hCS 22 8 8 7 5 10 26 
hCSA348G 11 4 5 1 1 5 13 
mcsA 12 8 8 4 4 8 14 
mcsAG352A 10 2 4 2 2 4 12 
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Table 4.5: Summary of calculated inhibitor constants and inhibition types for hCS and mcsA. 
 
 
Oxaloacetate Ki (mM) Oxaloacetate Ki (mM)
71.7 ± 20.0 34.4 ± 1.1, 193.4 ± 57.1
Competitive Mixed
24.2 ± 2.9 52.1 ± 19.0
Competitive Competitive
8.0 ± 1.3 16.6 ± 1.1
Competitive Noncompetitive
90.5 ± 29.7 23.6 ± 9.6, 90.6 ± 36.6
Competitive Mixed
14.2 ± 0.7, 169.3 ± 46.1 67.5 ± 17.7
Mixed Noncompetitive
20.0 ± 5.6, 116.4 ± 19.5 30.9 ± 4.9
Mixed Competitive
17.5 ± 5.2, 75.2 ± 3.3 97.3 ± 13.2
Mixed Noncompetitive
Maleic Acid
6.5 ± 1.6, 19.3 ± 7.3 62.1 ± 11.9
Mixed Noncompetitive
Malic Acid
73.0 ± 26.2 17.1 ± 6.2
Competitive Competitive
Dihydroxyfumaric Acid
14.6 ± 4.9 6.9 ± 1.2
Competitive Competitive
Potassium Hydroxycitrate
22.3 ± 1.9 45.1 ± 5.6
Competitive Competitive
3,3-thiodipropionic acid
hCS mcsA
Acetyl-CoA Ki (mM) Propionyl-CoA Ki (mM)
21.2 ± 0.6 23.1 ± 2.1
Competitive Competitive
3-phosphonopropionic acid
Inhibitor
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4.16 FIGURES 
 
 
Figure 4.1: The 2-methylcitrate Cycle and Citric Acid Cycle. The 2-methylcitrate cycle 
(left) is used by fungi to detoxify propionyl-CoA via the enzyme 2-methylcitrate synthase 
(mcsA). In humans, propionyl-CoA is converted to methylmalonyl-CoA (right) and fed 
into the citric acid cycle. McsA also can perform the same reaction as citrate synthase 
(hCS) in this cycle (both colored in orange). 
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Figure 4.2: Condensation reactions catalyzed by mcsA and hCS. A) Condensation 
reactions catalyzed by both hCS and mcsA. B) Reaction catalyzed by only mcsA. hCS 
cannot use propionyl-CoA as co-substrate.
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Figure 4.3: Sequence alignment of pCS, hCS, cCS and mcsA. Enzymes pCS, hCS and cCS all share over 91% sequence identity. 
HCS and mcsA share a 51% sequence identity. Conserved residues are highlighted in red. Conserved secondary structure is shown by 
blue boxes. Sequence alignment was performed with ESPript 3.0 [82]
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Figure 4.4: Secondary sequence conservation of pCS, hCS and cCS. Conserved 
residues are shown in dark purple and variable residues are shown in teal between these 
citrate synthases; figure was made using Consurf [127].  
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Figure 4.5: Crystal structure of hCS. A) Crystal structure of hCS (PDB code: 5UZR). 
Citrate synthases are homodimeric and form two active sites. Red arrows indicate the active 
sites. Each monomer is colored in cyan or brown and both contribute residues to each active 
site. A 180˚ rotation about the Y-Axis is shown. B) HCS rotation of 90˚ about the X-axis to 
show the dimer interface between monomers. The dimer interface area is about 6000 Å2. 
C) Zoomed in view of one active site of hCS. Several basic residues contribute to substrate 
binding. Residues from chain A are shown in cyan and residues from chain B in brown. 
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Figure 4.6: Secondary sequence conservation of hCS and mcsA. Highly conserved 
residues are shown in purple and variable residues shown in teal. Figure was made using 
Consurf [127]. 
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Figure 4.7: Comparison of conformational changes between hCS and mcsA. Both hCS 
and mcsA adopt “open,” “partially closed” or “closed” conformations upon binding 
substrate. All structures are shown as space-filling models with each monomer of the 
homodimer colored differently. Substrates are colored with red and yellow spheres. A) 
Apo-hCS (PDB code: 5UZR) “open” conformation. B) Holo-cCS (PDB code: 4CSC - 
homologue) in “closed” conformation with D-malate and acetyl-CoA bound in the active 
sites. C) Apo-mcsA (PDB code: 5UQO) in “open” conformation. D) Holo-mcsA (PDB 
code: 5UQR) with oxaloacetate bound in one active site (“partially closed” conformation) 
and oxaloacetate and ethyl-CoA bound in the other (“closed” conformation). 
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Figure 4.8: Crystal structure of mcsA with oxaloacetate and ethyl-CoA bound. A) 
McsA (PDB code: 5UQR) was co-crystallized with oxaloacetate (OAA) and ethyl-CoA. 
Oxaloacetate was present in both active sites whereas ethyl-CoA was only in one of them. 
B) Zoomed in view of the oxaloacetate binding. Residues from both chains involved in 
binding oxaloacetate are shown. C) Zoomed in view of ethyl-CoA binding. Several peptide 
bonds form salt bridges with the adenosine moiety of ethyl-CoA. Only K192 from the other 
chain seems to be involved in binding ethyl-CoA. 
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Figure 4.9: Residue movement comparison upon substrate binding by hCS and mcsA. 
Cartoon representations are shown for holo-cCS (PDB code: 4CSC – homologue) and 
holo-mcsA (PDB code: 5UQR). Overall residue movement in each chain between hCS and 
mcsA was compared. Comparison of only three residues are shown as spheres: W398 (hCS) 
and H404 (mcsA) in blue, L388 (hCS) and L394 (mcsA) in magenta, W333 (hCS) and 
W337 (mcsA) in yellow. Apo-enzyme residue positions are shown with transparent spheres 
and stick representation. The hinge region for each active site is shown by green spheres. 
A) Residue movement observed in apo-hCS (PDB code: 5UZR) and holo-cCS (PDB code: 
4CSC – homologue). B) Residue movement observed in apo-mcsA (5UQO) and holo-
mcsA (PDB code: 5UQR). Overall, the residues in hCS showed greater movement than the 
corresponding residues in mcsA which could imply a tighter “closed” conformation. 
Moreover, this may help explain substrate specificity between hCS and mcsA. 
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Figure 4.10: Ala348 in hCS and Gly352 in mcsA. Pictured are aligned cartoon 
representations of apo-hCS (PDB code: 5UZR) and apo-mcsA (PDB code: 5UQO). Apo-
hCS is colored in cyan and brown. Apo-mcsA is colored in pink and purple. One minor 
difference in the active sites are A348 in hCS and G352 in mcsA. The alanine in hCS was 
thought to possibly cause some steric clash with CoA substrate and was investigated 
further. 
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Figure 4.11: Crystal structure of hCSA348G. The hCSA348G crystal structure (5UZP) 
was aligned with pCS (PDB code: 4CTS – homologue with only OAA bound) to show 
difference in positioning of active site residues. OAA is bound in both active sites (red and 
yellow spheres) for both structures. Most of the active site residues are in their normal 
positions when OAA is bound except H347 and R448. In the stick representations, 4CTS 
residues H347, R448 and OAA are shown with transparency and parentheses. Furthermore, 
the A348G mutation seemed to hinder the formation of the acetyl-CoA binding site by 
preventing the “partially closed” conformation. 
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Figure 4.12: Crystal structure of mcsAG352A. A) mcsAG352A (PDB code: 5UQU) was 
co-crystallized with oxaloacetate and CoA-SH. Oxaloacetate (shown as red spheres) was 
bound in one active site, and the other contained a sulfate ion (SO42-) and CoA-SH. The 
sulfate came from the crystallization condition. Two other sulfate ions were also bound on 
the surface of the protein (shown as red and yellow spheres). B) Active site coordination 
of the sulfate ion. C) Active site coordination of CoA-SH. 
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Figure 4.13: Kinetic graphs of hCS, hCSA348G, mcsA and mcsAG352A (A-D). 
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Figure 4.13: Kinetic graphs of hCS, hCSA348G, mcsA and mcsAG352A (E-J). For hCS fitting, the Michaelis-Menten equation was 
used. For mcsA fitting, the Hill equation was used (displayed positive cooperativity). All x-axes (substrate concentration) are in 
micromolar (µM) and y-axes (initial velocity) are in micromolar per second (µM/sec). A, C, E, H) Varied oxaloacetate (OAA). B, D, 
F, I) Varied acetyl-CoA (A-CoA). G, J) Varied propionyl-CoA (P-CoA). Propionyl-CoA could not be used as co-substrate for hCS or 
hCSA348G. Abbreviations: OAA – Oxaloacetate, A-CoA – Acetyl-CoA, P-CoA – Propionyl-CoA.
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Figure 4.14: Ligands used for DSF. All ligands pictured, except trimethylcitrate, 
increased the thermal stability of mcsA and did not increase the thermal stability of hCS. 
  
 
1
0
8
 
 
Figure 4.15: Lineweaver-Burk plots and inhibitor kinetics (A-H). 
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Figure 4.15: Lineweaver-Burk plots and inhibitor kinetics (I-P). 
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Figure 4.15: Lineweaver-Burk plots and inhibitor kinetics (Q-X). All inhibitors (except hydroxycitrate) were tested with 
concentrations of 70 mM (orange), 40 mM (grey), 20 mM (yellow) and 0 mM inhibitor (blue, no inhibitor). Hydroxycitrate was tested 
with concentrations of 24 mM (orange), 16 mM (grey), 8.0 mM (yellow) and 0 mM inhibitor (blue, no inhibitor). Trimethylcitrate 
showed poor inhibition for both enzymes and is not shown. A-D) 3-phosphonopropionic acid. E-H) 3,3-thiodipropionic acid. I-L) 
Hydroxycitrate. M-P) Dihydroxyfumaric acid. Q-T) Malic acid. U-X) Maleic acid. 
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CHAPTER 5 
SUMMARY, CONCLUSIONS AND FUTURE DIRECTIONS 
 The work presented here focuses on proteins from two agricultural pests, 
Tetranychus urticae and Aspergillus fumigatus, and characterizing these proteins may set 
the foundation for the discovery of new pesticides. Chapter 1 focused on TuCyanase, a 
protein important in the detoxification of the toxic metabolite produced by plants, cyanate. 
TuCyanase was crystallized and had its structure determined then compared to the bacterial 
cyanases. Future work with this project would include testing different cyanase inhibitors, 
and possibly trying to express and crystallize TuCyanase without fusion partner MBP. This 
may also provide insight as to the purpose of the N-terminal domain of TuCyanase, and 
how it is related to the bacterial cyanases and what purpose it may serve.  
 Co-crystallization and soaking experiments with potential ligands may help explain 
how substrates enter and exit the active sites. The cellular localization of TuCyanase is not 
known, but could be determined using fluorescent probes or markers such as green 
fluorescent protein (GFP). Knowing the localization TuCyanase might explain the purpose 
of the negatively charged core of the decamer, and the significance of the TuCyanase 
decamer being less compact than the bacterial cyanases mentioned here.  Furthermore, 
studying the interaction between T. urticae carbonic anhydrases and TuCyanase may 
display how important both of these enzymes are for the survival of T. urticae and 
potentially lead to the development of new inhibitors towards these enzymes. Lastly, this 
is the first eukaryotic cyanase deposited to the PDB.
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 Chapter 2 focused on a Glutathione S-Transferase (TuGST) from T. urticae. GSTs 
are important to almost all forms of life, including both prokaryotic and eukaryotic 
organisms. For GSTs, reduced glutathione is normally used as substrate to detoxify a target 
xenobiotic and in turn, makes it more soluble and permits it to be excreted from cells as 
waste. A few GSTs have been studied in T. urticae already, but here a new GST was 
investigated. TuGST did not seem to have any obvious affinity for all the substrates tested 
except CDNB, in which it bound with negative cooperativity. The future directions of this 
project include trying crystallization optimization by using techniques such as Surface 
Entropy Reduction (SERp) to determine the actual crystal structure of this TuGST, 
although GST secondary structure is well-conserved and the predicted structure shown here 
is probably a fair representation.  
 Active site residues could be mutated to alanine, especially Ser11 (interacts with 
reduced thiol of GSH), to provide further validity to the predicted structure if a crystal 
structure for TuGST cannot be obtained. Although attempting to use fusion partners to 
promote the crystallization of TuGST could be pursued (such a thioredoxin, rubredoxin 
and lysozyme), it would most likely not work based on protein expression and kinetic 
results in which the fusion partners seemed to completely hinder TuGST activity. 
Furthermore, the compounds all tested by UV-Vis spectroscopy could be used with more 
sensitive techniques such as SPR or ITC to determine dissociation constants and could 
provide very informative results on the purpose of this TuGST in T. urticae. Another option 
is to use High Performance Liquid Chromatography-Mass Spec (HPLC-MS) to measure 
the amount of substrate consumed or product formed during a given time period. 
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 Chapter 3 described the function and crystal structure of an intradiol ring-cleavage 
dioxygenase from T. urticae. This type of enzyme is metalloprotein that utilizes an active 
site non-heme iron to degrade aromatic compounds. The typical target aromatic 
compounds of ID-RCDs is catechol, a compound found in plants that not only can serve as 
a self-defense chemical, but can also be a precursor molecule in some plant metabolic 
pathways. The ferric center of TuDioxygenase is coordinated by two tyrosines and two 
histidines which is common to most ID-RCDs. Based on the use of several bioinformatic 
programs, TuDioxygenase appears to only have one main domain which is the intradiol 
domain, despite the fact that SACTE_2871 (PDB code: 4ILT), the model used for 
molecular replacement of TuDioxygenase, contains a lignin-binding domain [93]. Both 
TuDioxygenase and SACTE_2871 contain signal peptides on the N-terminus, although the 
signal peptide for TuDioxygenase is predicted to be around 20 amino acids whereas the 
signal peptide for SACTE_2871 is around 40 amino acids [93].  
 Co-crystallization and crystal soaking with catechol and catechol derivatives could 
be performed to acquire holo-TuDioxygenase structures in which bidentate binding should 
occur of catechol to the active site iron. Kinetic assays need to be performed by UV-Vis 
spectroscopy to determine substrate specificity of TuDioxygenase for catechol and 
catechol derivatives (if any) or by using HPLC-MS as described for TuGST. 
Electroparamagnetic Resonance (EPR) can be performed to determine free radical 
formation during the reaction of catechol with TuDioxygenase which may provide more 
insight into interaction between substrate and the active site iron, and also provide 
information on the coordination spheres around the ferric center. Lastly, assays (such as 
DSF, EPR) or co-crystallization experiments could be performed with catechol-based 
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insecticides to observe if this TuDioxygenase may have implications in insecticide 
resistance. 
 Chapter 4 focused on 2-methylcitrate synthase (mcsA) from A. fumigatus which 
was compared and contrasted to a similar enzyme, human citrate synthase (hCS). 
Structurally, there were very few differences between mcsA and hCS, but it seems from 
the crystal structures that hCS may be able to form a tighter “closed” conformation than 
mcsA, which may attribute to its substrate specificity for only acetyl-CoA and not 
propionyl-CoA. Computational studies could be done to investigate the clamping motions 
between them, and ultimately may explain why mcsA displays positive cooperativity and 
hCS does not. The inhibitor studies performed here had interesting results, such that the 
type of inhibition towards hCS and mcsA seemed to be mostly different for the same 
inhibitor. Co-crystallizing the inhibitors tested here with either hCS or mcsA would provide 
a better explanation as to why different inhibition types are seen for each enzyme. Crystal 
soaking would probably not work as this has been tried in the past and will destroy the 
crystals, most likely due to the significant conformational changes that occur when the 
proteins bind ligands.  
 More DSF experiments can be performed to find any new potential mcsA-specific 
inhibitors. Alternatively, a 96-well plate reader may yield better (and more informative 
results), but difficulties may arise due to the fast catalysis performed by these enzymes. 
Organically synthesizing 2-methylcitryl-CoA analogue (or other similar CoA analogues) 
could be useful and informative if inhibitors that target the mcsA active site are still 
pursued. Allosteric inhibitors would be more ideal, but may prove challenging as mcsA 
and hCS are structurally similar and have similar surface charge distributions. Lastly, the 
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very first crystal structure of mcsA and hCS are reported here. There are several crystal 
structures for pCS and cCS in the PDB already; however, the hCS structures presented here 
are the first citrate synthase crystal structures from humans deposited in the PDB.
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